{
    "abstractText": "Department of Cardiothoracic Surgery, Weill Cornell Medicine, 525 E 68th St, New York City, NY 10065, USA; Department of Anesthesiology, Weill Cornell Medicine, 525 E 68th St, New York City, NY 10065, USA; Department of Medicine, Duke University Medical Center, 2301 Erwin Rd, Durham, NC 27710, USA; and Department of Cardiac Surgery, Baylor Scott & White Health, 621 North Hall Street, Dallas, TX 75226, USA",
    "authors": [
        {
            "affiliations": [],
            "name": "Mario Gaudino"
        },
        {
            "affiliations": [],
            "name": "Antonino Di Franco"
        },
        {
            "affiliations": [],
            "name": "Lisa Q. Rong"
        },
        {
            "affiliations": [],
            "name": "Jonathan Piccini"
        },
        {
            "affiliations": [],
            "name": "Michael Mack"
        }
    ],
    "id": "SP:1404d8b3b98f8a85a973fb2ce14aea3b9d6ef8e9",
    "references": [
        {
            "authors": [
                "SA Lubitz",
                "X Yin",
                "M Rienstra",
                "RB Schnabel",
                "AJ Walkey",
                "JW Magnani"
            ],
            "title": "Long-term outcomes of secondary atrial fibrillation in the community: the Framingham Heart Study",
            "venue": "Circulation 2015;131:1648\u20131655",
            "year": 2015
        },
        {
            "authors": [
                "M Gaudino",
                "A Di Franco",
                "LQ Rong",
                "D Cao",
                "CA Pivato",
                "GJ Soletti"
            ],
            "title": "Pericardial effusion provoking atrial fibrillation after cardiac surgery: JACC review topic of the week",
            "venue": "J Am Coll Cardiol 2022;79:2529\u20132539",
            "year": 2022
        },
        {
            "authors": [
                "WJ van Boven",
                "JR de Groot",
                "J. Kluin"
            ],
            "title": "A short cut to prevent postoperative atrial fibrillation",
            "venue": "Lancet Lond Engl 2021;398:2052\u20132053",
            "year": 2053
        },
        {
            "authors": [
                "NWE van den Berg",
                "J Neefs",
                "M Kawasaki",
                "FA Nariswari",
                "R Wesselink",
                "B Fabrizi"
            ],
            "title": "Extracellular matrix remodeling precedes atrial fibrillation: results of the PREDICT-AF trial",
            "venue": "Heart Rhythm 2021;18:2115\u20132125",
            "year": 2021
        },
        {
            "authors": [
                "SH Lee",
                "DR Kang",
                "JS Uhm",
                "J Shim",
                "JH Sung",
                "JY Kim"
            ],
            "title": "New-onset atrial fibrillation predicts long-term newly developed atrial fibrillation after coronary artery bypass graft",
            "venue": "Am Heart J 2014;167:593\u2013600.e1",
            "year": 2013
        },
        {
            "authors": [
                "RM Melduni",
                "HV Schaff",
                "KR Bailey",
                "SS Cha",
                "NM Ammash",
                "JB Seward"
            ],
            "title": "Implications of new-onset atrial fibrillation after cardiac surgery on long-term prognosis: a community-based study",
            "venue": "Am Heart J 2015;170:659\u2013668",
            "year": 2015
        },
        {
            "authors": [
                "G Frendl",
                "AC Sodickson",
                "MK Chung",
                "AL Waldo",
                "BJ Gersh",
                "JE Tisdale"
            ],
            "title": "AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures",
            "venue": "J Thorac Cardiovasc Surg 2014;148:",
            "year": 2014
        },
        {
            "authors": [
                "G Filardo",
                "BD Pollock",
                "B da Graca",
                "TK Phan",
                "DM Sass",
                "G Ailawadi"
            ],
            "title": "Underestimation of the incidence of new-onset post-coronary artery bypass grafting atrial fibrillation and its impact on 30-day mortality",
            "venue": "J Thorac Cardiovasc Surg",
            "year": 2017
        },
        {
            "authors": [
                "M Gaudino",
                "T Sanna",
                "KV Ballman",
                "NB Robinson",
                "I Hameed",
                "K Audisio"
            ],
            "title": "Posterior left pericardiotomy for the prevention of atrial fibrillation after cardiac surgery: an adaptive, single-centre, single-blind, randomised, controlled trial",
            "year": 2083
        },
        {
            "authors": [
                "R Carter-Storch",
                "JS Dahl",
                "NL Christensen",
                "R Pecini",
                "EV S\u00f8nderg\u00e5rd",
                "KA \u00d8vrehus"
            ],
            "title": "Postoperative atrial fibrillation after aortic valve replacement is a risk factor for longterm atrial fibrillation",
            "venue": "Interact Cardiovasc Thorac Surg 2019;29:378\u2013385",
            "year": 2019
        },
        {
            "authors": [
                "A Zangrillo",
                "G Landoni",
                "D Sparicio",
                "S Benussi",
                "G Aletti",
                "F Pappalardo"
            ],
            "title": "Predictors of atrial fibrillation after off-pump coronary artery bypass graft surgery",
            "venue": "J Cardiothorac Vasc Anesth 2004;18:704\u2013708",
            "year": 2004
        },
        {
            "authors": [
                "JW Greenberg",
                "TS Lancaster",
                "RB Schuessler",
                "SJ. Melby"
            ],
            "title": "Postoperative atrial fibrillation following cardiac surgery: a persistent complication",
            "venue": "Eur J Cardiothorac Surg",
            "year": 2017
        },
        {
            "authors": [
                "BA Steinberg",
                "Y Zhao",
                "X He",
                "AF Hernandez",
                "DA Fullerton",
                "KL Thomas"
            ],
            "title": "Management of postoperative atrial fibrillation and subsequent outcomes in contemporary patients undergoing cardiac surgery: insights from the Society of Thoracic Surgeons CAPS-Care Atrial Fibrillation Registry",
            "venue": "Clin Cardiol 2014;37:7\u201313",
            "year": 2014
        },
        {
            "authors": [
                "A Ahlsson",
                "E Fengsrud",
                "L Bodin",
                "A. Englund"
            ],
            "title": "Postoperative atrial fibrillation in patients undergoing aortocoronary bypass surgery carries an eightfold risk of future atrial fibrillation and a doubled cardiovascular mortality",
            "venue": "Eur J Cardiothorac Surg",
            "year": 2009
        },
        {
            "authors": [
                "JA Fuller",
                "GG Adams",
                "B. Buxton"
            ],
            "title": "Atrial fibrillation after coronary artery bypass grafting. Is it a disorder of the elderly",
            "venue": "J Thorac Cardiovasc Surg 1989;97:821\u2013825",
            "year": 1989
        },
        {
            "authors": [
                "J Lahtinen",
                "F Biancari",
                "E Salmela",
                "M Mosorin",
                "J Satta",
                "P Rainio"
            ],
            "title": "Postoperative atrial fibrillation is a major cause of stroke after on-pump coronary artery bypass surgery",
            "venue": "Ann Thorac Surg 2004;77:1241\u20131244",
            "year": 2003
        },
        {
            "authors": [
                "DS Likosky",
                "LR Caplan",
                "RM Weintraub",
                "GS Hartman",
                "DJ Malenka",
                "CS Ross"
            ],
            "title": "Intraoperative and postoperative variables associated with strokes following cardiac surgery",
            "venue": "Heart Surg Forum 2004;7:E271\u2013E276",
            "year": 2004
        },
        {
            "authors": [
                "FG Fernandez",
                "DM Shahian",
                "R Kormos",
                "JP Jacobs",
                "RS D\u2019Agostino",
                "JE Mayer"
            ],
            "title": "The society of thoracic surgeons national database 2019 annual report",
            "venue": "Ann Thorac Surg 2019;108:1625\u20131632",
            "year": 2019
        },
        {
            "authors": [
                "JP Mathew",
                "ML Fontes",
                "IC Tudor",
                "J Ramsay",
                "P Duke",
                "CD Mazer"
            ],
            "title": "A multicenter risk index for atrial fibrillation after cardiac surgery",
            "venue": "JAMA 2004;291:1720\u20131729",
            "year": 2004
        },
        {
            "authors": [
                "D Dobrev",
                "M Aguilar",
                "J Heijman",
                "J-B Guichard",
                "S. Nattel"
            ],
            "title": "Postoperative atrial fibrillation: mechanisms, manifestations and management",
            "venue": "Nat Rev Cardiol 2019;16:417\u2013436",
            "year": 2019
        },
        {
            "authors": [
                "R Zhao",
                "Z Wang",
                "F Cao",
                "J Song",
                "S Fan",
                "J Qiu"
            ],
            "title": "New-Onset postoperative atrial fibrillation after total arch repair is associated with increased in-hospital mortality",
            "venue": "J Am Heart Assoc 2021;10:e021980",
            "year": 2198
        },
        {
            "authors": [
                "E Akintoye",
                "F Sellke",
                "R Marchioli",
                "L Tavazzi",
                "D. Mozaffarian"
            ],
            "title": "Factors associated with postoperative atrial fibrillation and other adverse events after cardiac surgery",
            "venue": "J Thorac Cardiovasc Surg 2018;155:242\u2013251",
            "year": 2017
        },
        {
            "authors": [
                "M Vaseghi",
                "NG Boyle",
                "R Kedia",
                "JK Patel",
                "DA Cesario",
                "I Wiener"
            ],
            "title": "Supraventricular tachycardia after orthotopic cardiac transplantation",
            "venue": "J Am Coll Cardiol",
            "year": 2008
        },
        {
            "authors": [
                "Tsai Y-T",
                "Lai C-H",
                "Loh S-H",
                "Lin C-Y",
                "Lin Y-C",
                "Lee C-Y"
            ],
            "title": "Assessment of the risk factors and outcomes for postoperative atrial fibrillation patients undergoing isolated coronary artery bypass grafting",
            "venue": "Acta Cardiol Sin 2015;31:436\u2013443",
            "year": 2015
        },
        {
            "authors": [
                "TC Andrews",
                "SC Reimold",
                "JA Berlin",
                "EM. Antman"
            ],
            "title": "Prevention of supraventricular arrhythmias after coronary artery bypass surgery. A meta-analysis of randomized control trials. Circulation 1991;84:III236\u2013III244",
            "year": 1991
        },
        {
            "authors": [
                "B Shahim",
                "SC Malaisrie",
                "I George",
                "VH Thourani",
                "AB Biviano",
                "M Russo"
            ],
            "title": "Postoperative atrial fibrillation or flutter following transcatheter or surgical aortic valve replacement: PARTNER 3 trial",
            "venue": "JACC Cardiovasc Interv 2021;14:1565\u20131574. https://doi",
            "year": 2021
        },
        {
            "authors": [
                "A Sannino",
                "G Gargiulo",
                "GG Schiattarella",
                "C Perrino",
                "E Stabile",
                "MA Losi"
            ],
            "title": "A meta-analysis of the impact of pre-existing and new-onset atrial fibrillation on clinical outcomes in patients undergoing transcatheter aortic valve implantation. EuroIntervention 2016;12:e1047\u2013e1056",
            "year": 2016
        },
        {
            "authors": [
                "G Gargiulo",
                "D Capodanno",
                "A Sannino",
                "M Barbanti",
                "C Perrino",
                "P Capranzano"
            ],
            "title": "New-onset atrial fibrillation and increased mortality after transcatheter aortic valve implantation: a causal or spurious association",
            "venue": "Int J Cardiol",
            "year": 2016
        },
        {
            "authors": [
                "G Tarantini",
                "M Mojoli",
                "M Urena",
                "A. Vahanian"
            ],
            "title": "Atrial fibrillation in patients undergoing transcatheter aortic valve implantation: epidemiology, timing, predictors, and outcome",
            "venue": "Eur Heart J 2017;38:1285\u20131293",
            "year": 2017
        },
        {
            "authors": [
                "LJ Motloch",
                "S Reda",
                "D Rottlaender",
                "R Khatib",
                "J M\u00fcller-Ehmsen",
                "C Seck"
            ],
            "title": "Postprocedural atrial fibrillation after transcatheter aortic valve implantation versus surgical aortic valve replacement",
            "venue": "Ann Thorac Surg",
            "year": 2012
        },
        {
            "authors": [
                "TH J\u00f8rgensen",
                "JB Thygesen",
                "HG Thyregod",
                "JH Svendsen",
                "L. S\u00f8ndergaard"
            ],
            "title": "New-onset atrial fibrillation after surgical aortic valve replacement and transcatheter aortic valve implantation: a concise review",
            "venue": "J Invasive Cardiol",
            "year": 2015
        },
        {
            "authors": [
                "D Amar",
                "N Roistacher",
                "M Burt",
                "RA Reinsel",
                "RJ Ginsberg",
                "RS. Wilson"
            ],
            "title": "Clinical and echocardiographic correlates of symptomatic tachydysrhythmias after noncardiac thoracic surgery",
            "venue": "Chest 1995;108:349\u2013354",
            "year": 1995
        },
        {
            "authors": [
                "AA Vaporciyan",
                "AM Correa",
                "DC Rice",
                "JA Roth",
                "WR Smythe",
                "SG Swisher"
            ],
            "title": "Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients",
            "venue": "J Thorac Cardiovasc Surg 2004;127:779\u2013786",
            "year": 2003
        },
        {
            "authors": [
                "RS Passman",
                "DS Gingold",
                "D Amar",
                "D Lloyd-Jones",
                "CL Bennett",
                "H Zhang"
            ],
            "title": "Prediction rule for atrial fibrillation after major noncardiac thoracic surgery",
            "venue": "Ann Thorac Surg 2005;79:1698\u20131703",
            "year": 2004
        },
        {
            "authors": [
                "Merritt RE",
                "Shrager JB"
            ],
            "title": "Prophylaxis and management of atrial fibrillation after general thoracic surgery",
            "venue": "Thorac Surg Clin 2012;221:13\u201323",
            "year": 2012
        },
        {
            "authors": [
                "A AlTurki",
                "M Marafi",
                "R Proietti",
                "D Cardinale",
                "R Blackwell",
                "P Dorian"
            ],
            "title": "Major adverse cardiovascular events associated with postoperative atrial fibrillation after noncardiac POAF mechanisms and treatment 1037 D ow naded rom http/academ ic.p.com /eurheartj/a4/12/1020/7017633 by Idian Intitute of Tenology Ptna user on 13 Jauary 2024 surgery: a systematic review and meta-analysis",
            "venue": "Circ Arrhythm Electrophysiol 2020;13:",
            "year": 2020
        },
        {
            "authors": [
                "CA Polanczyk",
                "L Goldman",
                "ER Marcantonio",
                "EJ Orav",
                "TH. Lee"
            ],
            "title": "Supraventricular arrhythmia in patients having noncardiac surgery: clinical correlates and effect on length of stay",
            "venue": "Ann Intern Med",
            "year": 1998
        },
        {
            "authors": [
                "GS Batra",
                "J Molyneux",
                "NA. Scott"
            ],
            "title": "Colorectal patients and cardiac arrhythmias detected on the surgical high dependency unit",
            "venue": "Ann R Coll Surg Engl 2001;83:174\u2013176",
            "year": 2001
        },
        {
            "authors": [
                "KK Christians",
                "B Wu",
                "EJ Quebbeman",
                "KJ. Brasel"
            ],
            "title": "Postoperative atrial fibrillation in noncardiothoracic surgical patients",
            "venue": "Am J Surg 2001;182:713\u2013715",
            "year": 2001
        },
        {
            "authors": [
                "SR Walsh",
                "T Tang",
                "C Wijewardena",
                "SI Yarham",
                "JR Boyle",
                "ME. Gaunt"
            ],
            "title": "Postoperative arrhythmias in general surgical patients",
            "venue": "Ann R Coll Surg Engl 2007;89:91\u201395. https://doi",
            "year": 2007
        },
        {
            "authors": [
                "GH Sohn",
                "D-H Shin",
                "KM Byun",
                "HJ Han",
                "SJ Cho",
                "YB Song"
            ],
            "title": "The incidence and predictors of postoperative atrial fibrillation after noncardiothoracic surgery",
            "venue": "Korean Circ J 2009;39:100\u2013104",
            "year": 2009
        },
        {
            "authors": [
                "PD Bhave",
                "LE Goldman",
                "E Vittinghoff",
                "J Maselli",
                "A. Auerbach"
            ],
            "title": "Incidence, predictors, and outcomes associated with postoperative atrial fibrillation after major noncardiac surgery",
            "venue": "Am Heart J 2012;164:918\u2013924",
            "year": 2012
        },
        {
            "authors": [
                "KC Siontis",
                "BJ Gersh",
                "SA Weston",
                "R Jiang",
                "VL Roger",
                "PA Noseworthy"
            ],
            "title": "Associations of atrial fibrillation after noncardiac surgery with stroke, subsequent arrhythmia, and death: a cohort study",
            "venue": "Ann Intern Med 2022;175:1065\u20131072. https://doi",
            "year": 2022
        },
        {
            "authors": [
                "LH Prince-Wright",
                "O Akinyemi",
                "SO Nnorom",
                "ES Bauer",
                "EE Cornwell Iii",
                "TM. Fullum"
            ],
            "title": "Postoperative atrial fibrillation following non-cardiac surgery: predictors and risk of mortality",
            "venue": "Am J Surg 2022;22:1062\u20131067",
            "year": 2022
        },
        {
            "authors": [
                "Y Ishii",
                "RB Schuessler",
                "SL Gaynor",
                "K Yamada",
                "AS Fu",
                "JP Boineau"
            ],
            "title": "Inflammation of atrium after cardiac surgery is associated with inhomogeneity of atrial conduction and atrial fibrillation. Circulation 2005;111:2881\u20132888",
            "year": 2005
        },
        {
            "authors": [
                "P Bruins",
                "H Velthuis",
                "AP. Yazdanbakhsh"
            ],
            "title": "Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia",
            "year": 1997
        },
        {
            "authors": [
                "Ho KM",
                "Tan JA"
            ],
            "title": "Benefits and risks of corticosteroid prophylaxis in adult cardiac surgery: a dose-response meta-analysis",
            "venue": "Circulation 2009;119:1853\u20131866. https://doi",
            "year": 2009
        },
        {
            "authors": [
                "M Imazio",
                "A Brucato",
                "P. Ferrazzi"
            ],
            "title": "Colchicine reduces postoperative atrial fibrillation: results of the Colchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS) atrial fibrillation substudy. Circulation 2011;124:2290\u20132295",
            "year": 2011
        },
        {
            "authors": [
                "K Ryu",
                "L Li",
                "CM Khrestian",
                "N Matsumoto",
                "J Sahadevan",
                "ML Ruehr"
            ],
            "title": "Effects of sterile pericarditis on connexins 40 and 43 in the atria: correlation with abnormal conduction and atrial arrhythmias",
            "venue": "Am J Physiol Heart Circ Physiol 2007;293:H1231\u2013H1241. https:// doi.org/10.1152/ajpheart.00607.2006",
            "year": 2006
        },
        {
            "authors": [
                "EI Rossman",
                "K Liu",
                "GA. Morgan"
            ],
            "title": "The gap junction modifier, GAP-134 [(2S,4R)-1-(2-aminoacetyl)-4-benzamido-pyrrolidine-2-carboxylic acid], improves conduction and reduces atrial fibrillation/flutter in the canine sterile pericarditis model",
            "venue": "J Pharmacol Exp Ther 2009;329:1127\u20131133",
            "year": 2009
        },
        {
            "authors": [
                "S St-Onge",
                "LP Perrault",
                "P. Demers"
            ],
            "title": "Pericardial blood as a trigger for postoperative atrial fibrillation after cardiac surgery",
            "venue": "Ann Thorac Surg 2018;105:321\u2013328",
            "year": 2017
        },
        {
            "authors": [
                "CX Wong",
                "MT Sun",
                "A. Odutayo"
            ],
            "title": "Associations of epicardial, abdominal, and overall adiposity with atrial fibrillation",
            "venue": "Circ Arrhythm Electrophysiol 2016;912:e004378. https://doi",
            "year": 2016
        },
        {
            "authors": [
                "CX Wong",
                "AN Ganesan",
                "JB. Selvanayagam"
            ],
            "title": "Epicardial fat and atrial fibrillation: current evidence, potential mechanisms, clinical implications, and future directions",
            "venue": "Eur Heart J 2017;38:1294\u20131302",
            "year": 2017
        },
        {
            "authors": [
                "AC Ernault",
                "AO Verkerk",
                "JD. Bayer"
            ],
            "title": "Secretome of atrial epicardial adipose tissue facilitates reentrant arrhythmias by myocardial remodeling",
            "venue": "Heart Rhythm",
            "year": 2022
        },
        {
            "authors": [
                "S Cabaro",
                "M Conte",
                "D. Moschetta"
            ],
            "title": "Epicardial adipose tissue-derived IL-1beta triggers postoperative atrial fibrillation",
            "venue": "Front Cell Dev Biol",
            "year": 2022
        },
        {
            "authors": [
                "A Viviano",
                "X Yin",
                "A. Zampetaki"
            ],
            "title": "Proteomics of the epicardial fat secretome and its role in post-operative atrial fibrillation",
            "venue": "Europace 2018;20:1201\u20131208",
            "year": 2018
        },
        {
            "authors": [
                "M Gozdek",
                "W Pawliszak",
                "W Hagner",
                "P Zalewski",
                "J Kowalewski",
                "D Paparella"
            ],
            "title": "Systematic review and meta-analysis of randomized controlled trials assessing safety and efficacy of posterior pericardial drainage in patients undergoing heart surgery",
            "venue": "J Thorac Cardiovasc Surg 2017;153:865\u2013875.e12",
            "year": 2016
        },
        {
            "authors": [
                "SD Pokorney",
                "SI Berchuck",
                "K. Chiswell"
            ],
            "title": "Atrial branch coronary artery stenosis as a mechanism for atrial fibrillation",
            "venue": "Heart Rhythm",
            "year": 2022
        },
        {
            "authors": [
                "CI Tchervenkov",
                "JE Wynands",
                "JF Symes",
                "ID Malcolm",
                "AR Dobell",
                "JE. Morin"
            ],
            "title": "Persistent atrial activity during cardioplegic arrest: a possible factor in the etiology of postoperative supraventricular tachyarrhythmias",
            "venue": "Ann Thorac Surg 1983;36:437\u2013443",
            "year": 1983
        },
        {
            "authors": [
                "P Zhang",
                "L Wang",
                "K. Zhai"
            ],
            "title": "Off-pump versus on-pump redo coronary artery bypass grafting: a systematic review and meta-analysis. Perfusion 2021;36:724\u2013736",
            "year": 1209
        },
        {
            "authors": [
                "LM Burgos",
                "AG Ramirez",
                "L. Seoane"
            ],
            "title": "New combined risk score to predict atrial fibrillation after cardiac surgery: COM-AF",
            "venue": "Ann Card Anaesth 2021;24:458\u2013463. https://doi",
            "year": 2021
        },
        {
            "authors": [
                "AJ Workman",
                "D Pau",
                "CJ Redpath",
                "GE Marshall",
                "JA Russell",
                "KA Kane"
            ],
            "title": "Post-operative atrial fibrillation is influenced by beta-blocker therapy but not by preoperative atrial cellular electrophysiology",
            "venue": "J Cardiovasc Electrophysiol",
            "year": 2006
        },
        {
            "authors": [
                "D Dobrev",
                "E Wettwer",
                "A Kortner",
                "M Knaut",
                "S Schuler",
                "U. Ravens"
            ],
            "title": "Human inward rectifier potassium channels in chronic and postoperative atrial fibrillation",
            "venue": "Cardiovasc Res 2002;54:397\u2013404",
            "year": 2002
        },
        {
            "authors": [
                "C Dimmer",
                "R Tavernier",
                "N Gjorgov",
                "G Nooten",
                "DL Clement",
                "L. Jordaens"
            ],
            "title": "Variations of autonomic tone preceding onset of atrial fibrillation after coronary artery bypass grafting",
            "venue": "Am J Cardiol 1998;82:22\u201325",
            "year": 1998
        },
        {
            "authors": [
                "MF Karatela",
                "M Fudim",
                "JP Mathew",
                "JP. Piccini"
            ],
            "title": "Neuromodulation therapy for atrial fibrillation",
            "venue": "Heart Rhythm 2023;20:100\u2013111",
            "year": 2022
        },
        {
            "authors": [
                "M Zimmermann",
                "D. Kalusche"
            ],
            "title": "Fluctuation in autonomic tone is a major determinant of sustained atrial arrhythmias in patients with focal ectopy originating from the pulmonary veins",
            "venue": "J Cardiovasc Electrophysiol 2001;12:285\u2013291",
            "year": 2001
        },
        {
            "authors": [
                "D Amar",
                "H Zhang",
                "S Miodownik",
                "AH. Kadish"
            ],
            "title": "Competing autonomic mechanisms precede the onset of postoperative atrial fibrillation",
            "venue": "J Am Coll Cardiol 2003;42:1262\u20131268",
            "year": 2003
        },
        {
            "authors": [
                "JM Kalman",
                "M Munawar",
                "LG. Howes"
            ],
            "title": "Atrial fibrillation after coronary artery bypass grafting is associated with sympathetic activation",
            "venue": "Ann Thorac Surg",
            "year": 1995
        },
        {
            "authors": [
                "E Patterson",
                "R Lazzara",
                "B. Szabo"
            ],
            "title": "Sodium-calcium exchange initiated by the Ca transient: an arrhythmia trigger within pulmonary veins",
            "venue": "J Am Coll Cardiol",
            "year": 2005
        },
        {
            "authors": [
                "M Ha\u00efssaguerre",
                "P Ja\u00efs",
                "DC Shah",
                "A Takahashi",
                "M Hocini",
                "G Quiniou"
            ],
            "title": "Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins",
            "venue": "N Engl J Med",
            "year": 1998
        },
        {
            "authors": [
                "AS Omran",
                "A Karimi",
                "H Ahmadi",
                "P Yazdanifard",
                "M Sheikh Fahtollahi",
                "M. Tazik"
            ],
            "title": "Prophylactic ventral cardiac denervation: does it reduce incidence of atrial fibrillation after coronary artery bypass grafting",
            "venue": "J Thorac Cardiovasc Surg 2010;140:1036\u20131039",
            "year": 2009
        },
        {
            "authors": [
                "E Pokushalov",
                "B Kozlov",
                "A Romanov",
                "A Strelnikov",
                "S Bayramova",
                "D Sergeevichev"
            ],
            "title": "Long-term suppression of atrial fibrillation by botulinum toxin injection into epicardial fat pads in patients undergoing cardiac surgery: one-year follow-up of a randomized pilot study",
            "venue": "Circ Arrhythm Electrophysiol 2015;8:1334\u20131341",
            "year": 2015
        },
        {
            "authors": [
                "H Wang",
                "Y Zhang",
                "F Xin",
                "H Jiang",
                "D Tao",
                "Y Jin"
            ],
            "title": "Calcium-induced autonomic denervation in patients with post-operative atrial fibrillation",
            "venue": "J Am Coll Cardiol 2021;77:",
            "year": 2020
        },
        {
            "authors": [
                "NH Waldron",
                "M Cooter",
                "JC. Haney"
            ],
            "title": "Temporary autonomic modulation with botulinum toxin type A to reduce atrial fibrillation after cardiac surgery",
            "venue": "Heart Rhythm 2019;16:178\u2013184",
            "year": 2018
        },
        {
            "authors": [
                "DJ LaPar",
                "AM Speir",
                "IK Crosby",
                "E Fonner",
                "M Brown",
                "JB Rich"
            ],
            "title": "Postoperative atrial fibrillation significantly increases mortality, hospital readmission, and hospital costs",
            "venue": "Ann Thorac Surg. 2014;98:527\u2013533; discussion 533",
            "year": 2014
        },
        {
            "authors": [
                "U Benedetto",
                "MF Gaudino",
                "A Dimagli",
                "S Gerry",
                "A Gray",
                "B Lees"
            ],
            "title": "Postoperative atrial fibrillation and long-term risk of stroke after isolated coronary artery bypass graft surgery",
            "venue": "Circulation 2020;142:1320\u20131329",
            "year": 2020
        },
        {
            "authors": [
                "P Goyal",
                "M Kim",
                "U Krishnan",
                "SA Mccullough",
                "JW Cheung",
                "LK Kim"
            ],
            "title": "Post-operative atrial fibrillation and risk of heart failure hospitalization",
            "venue": "Eur Heart J",
            "year": 2022
        },
        {
            "authors": [
                "T Caldonazo",
                "H Kirov",
                "M Rahouma",
                "NB Robinson",
                "M Demetres",
                "M Gaudino"
            ],
            "title": "Atrial fibrillation after cardiac surgery: a systematic review and meta-analysis",
            "venue": "J Thorac Cardiovasc Surg 2023;165:94\u2013103.e24",
            "year": 2021
        },
        {
            "authors": [
                "R Eikelboom",
                "R Sanjanwala",
                "ML Le",
                "MH Yamashita",
                "RC. Arora"
            ],
            "title": "Postoperative atrial fibrillation after cardiac surgery: a systematic review and meta-analysis",
            "venue": "Ann Thorac Surg 2021;111:544\u2013554",
            "year": 2020
        },
        {
            "authors": [
                "GH Almassi",
                "RB Hawkins",
                "M Bishawi",
                "AL Shroyer",
                "B Hattler",
                "JA Quin"
            ],
            "title": "New-onset postoperative atrial fibrillation impact on 5-year clinical outcomes and costs",
            "venue": "J Thorac Cardiovasc Surg 2021;161:1803\u20131810.e3",
            "year": 2019
        },
        {
            "authors": [
                "W Rosamond",
                "K Flegal",
                "G Friday",
                "K Furie",
                "A Go",
                "K Greenlund"
            ],
            "title": "Heart disease and stroke statistics\u20132007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee",
            "venue": "Circulation 2007;115:e69\u2013171. https://doi.org/10.1161/CIRCULATIONAHA.106.179918 1038 M. Gaudino et al. D ow naded rom http/academ ic.p.com /eurheartj/a4/12/1020/7017633 by Idian Intitute of Tenology Ptna user on 13 Jauary",
            "year": 2024
        },
        {
            "authors": [
                "N Echahidi",
                "P Pibarot",
                "G O\u2019Hara",
                "P. Mathieu"
            ],
            "title": "Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery",
            "venue": "J Am Coll Cardiol 2008;51:793\u2013801. https://doi",
            "year": 2007
        },
        {
            "authors": [
                "MH Lin",
                "H Kamel",
                "DE Singer",
                "YL Wu",
                "M Lee",
                "B. Ovbiagele"
            ],
            "title": "Perioperative/postoperative atrial fibrillation and risk of subsequent stroke and/or mortality. Stroke",
            "year": 2019
        },
        {
            "authors": [
                "G Hindricks",
                "T Potpara",
                "N Dagres",
                "E Arbelo",
                "JJ Bax",
                "C Blomstr\u00f6m-Lundqvist"
            ],
            "title": "2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European society of cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC",
            "venue": "Eur Heart J 2021;42:373\u2013498",
            "year": 2021
        },
        {
            "authors": [
                "Kim SH",
                "Jang M-J",
                "Hwang HY"
            ],
            "title": "Perioperative beta-blocker for atrial fibrillation after cardiac surgery: a meta-analysis. Thorac Cardiovasc Surg 2021;69:133\u2013140",
            "year": 2021
        },
        {
            "authors": [
                "KA Arsenault",
                "AM Yusuf",
                "E Crystal",
                "JS Healey",
                "CA Morillo",
                "GM Nair"
            ],
            "title": "Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery",
            "venue": "Cochrane Database Syst Rev 2013;2013:CD003611",
            "year": 2013
        },
        {
            "authors": [
                "MF Khan",
                "CS Wendel",
                "MR. Movahed"
            ],
            "title": "Prevention of post-coronary artery bypass grafting (CABG) atrial fibrillation: efficacy of prophylactic beta-blockers in the modern era: a meta-analysis of latest randomized controlled trials",
            "venue": "Ann Noninvasive Electrocardiol 2013;18:58\u201368",
            "year": 1200
        },
        {
            "authors": [
                "POISE Study Group",
                "PJ Devereaux",
                "H Yang",
                "S Yusuf",
                "G Guyatt",
                "K Leslie"
            ],
            "title": "Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial",
            "venue": "https://doi",
            "year": 2008
        },
        {
            "authors": [
                "H Blessberger",
                "SR Lewis",
                "MW Pritchard",
                "LJ Fawcett",
                "H Domanovits",
                "O Schlager"
            ],
            "title": "Perioperative beta-blockers for preventing surgery-related mortality and morbidity in adults undergoing non-cardiac surgery",
            "venue": "Cochrane Database Syst Rev 2019;9:CD013438",
            "year": 2019
        },
        {
            "authors": [
                "S. Nattel"
            ],
            "title": "The molecular and ionic specificity of antiarrhythmic drug actions",
            "venue": "J Cardiovasc Electrophysiol 1999;10:272\u2013282",
            "year": 1999
        },
        {
            "authors": [
                "LB Mitchell",
                "DV Exner",
                "DG Wyse",
                "CJ Connolly",
                "GD Prystai",
                "AJ Bayes"
            ],
            "title": "Prophylactic oral amiodarone for the prevention of arrhythmias that begin early after revascularization, valve replacement, or repair: PAPABEAR: a randomized controlled trial",
            "venue": "JAMA 2005;294:3093\u20133100",
            "year": 2005
        },
        {
            "authors": [
                "MS Buckley",
                "PE Nolan",
                "MK Slack",
                "JE Tisdale",
                "DE Hilleman",
                "JG. Copeland"
            ],
            "title": "Amiodarone prophylaxis for atrial fibrillation after cardiac surgery: meta-analysis of dose response and timing of initiation. Pharmacotherapy 2007;27:360\u2013368",
            "year": 2007
        },
        {
            "authors": [
                "N Goldschlager",
                "AE Epstein",
                "G Naccarelli",
                "B Olshansky",
                "B. Singh"
            ],
            "title": "Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology",
            "venue": "Arch Intern Med",
            "year": 2000
        },
        {
            "authors": [
                "H Ashrafian",
                "P. Davey"
            ],
            "title": "Is amiodarone an underrecognized cause of acute respiratory failure in the ICU? Chest 2001;120:275\u2013282",
            "year": 2001
        },
        {
            "authors": [
                "M Saussine",
                "P Colson",
                "M Alauzen",
                "H. Mary"
            ],
            "title": "Postoperative acute respiratory distress syndrome. A complication of amiodarone associated with 100% oxygen ventilation",
            "venue": "Chest 1992;102:980\u2013981",
            "year": 1992
        },
        {
            "authors": [
                "DC Burgess",
                "MJ Kilborn",
                "AC. Keech"
            ],
            "title": "Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis",
            "venue": "Eur Heart J 2006;272:2846\u20132857",
            "year": 2006
        },
        {
            "authors": [
                "AN Mooss",
                "RL Wurdeman",
                "JT Sugimoto",
                "KA Packard",
                "DE Hilleman",
                "TL Lenz"
            ],
            "title": "Amiodarone versus sotalol for the treatment of atrial fibrillation after open heart surgery: the Reduction in Postoperative Cardiovascular Arrhythmic Events (REDUCE) trial",
            "venue": "Am Heart J 2004;148:641\u2013648",
            "year": 2004
        },
        {
            "authors": [
                "DN Wijeysundera",
                "WS Beattie",
                "V Rao",
                "J. Karski"
            ],
            "title": "Calcium antagonists reduce cardiovascular complications after cardiac surgery: a meta-analysis",
            "venue": "J Am Coll Cardiol",
            "year": 2003
        },
        {
            "authors": [
                "H Parikka",
                "L Toivonen",
                "T Pellinen",
                "K Verkkala",
                "A Jarvinen",
                "MS. Nieminen"
            ],
            "title": "The influence of intravenous magnesium sulphate on the occurrence of atrial fibrillation after coronary artery by-pass operation",
            "venue": "Eur Heart J 1993;14:251\u2013258",
            "year": 1993
        },
        {
            "authors": [
                "G Baradari A",
                "E Zeydi A",
                "R Ghafari",
                "M Aarabi",
                "M. Jafari"
            ],
            "title": "A double-blind randomized clinical trial comparing different doses of magnesium in cardioplegic solution for prevention of atrial fibrillation after coronary artery bypass graft surgery",
            "venue": "Cardiovasc Ther 2016;34:276\u2013282",
            "year": 2016
        },
        {
            "authors": [
                "RY Klinger",
                "CA Thunberg",
                "WD. White"
            ],
            "title": "Intraoperative magnesium administration does not reduce postoperative atrial fibrillation after cardiac surgery",
            "venue": "Anesth Analg",
            "year": 2015
        },
        {
            "authors": [
                "S Miller",
                "E Crystal",
                "M Garfinkle",
                "C Lau",
                "I Lashevsky",
                "SJ. Connolly"
            ],
            "title": "Effects of magnesium on atrial fibrillation after cardiac surgery: a meta-analysis",
            "venue": "Heart 2005;91:618\u2013623",
            "year": 2004
        },
        {
            "authors": [
                "RC Cook",
                "MH Yamashita",
                "M Kearns",
                "K Ramanathan",
                "K Gin",
                "KH. Humphries"
            ],
            "title": "Prophylactic magnesium does not prevent atrial fibrillation after cardiac surgery: a meta-analysis",
            "venue": "Ann Thorac Surg 2013;95:533\u2013541",
            "year": 2012
        },
        {
            "authors": [
                "RA Tabbalat",
                "I Alhaddad",
                "A Hammoudeh",
                "YS Khader",
                "HA Khalaf",
                "M Obaidat"
            ],
            "title": "Effect of low-dose ColchiciNe on the InciDence of atrial fibrillation in open heart surgery patients: END-AF low dose trial",
            "venue": "J Int Med Res 2020;48:300060520939832",
            "year": 2093
        },
        {
            "authors": [
                "T Levy",
                "G Fotopoulos",
                "S Walker",
                "S Rex",
                "M Octave",
                "V Paul"
            ],
            "title": "Randomized controlled study investigating the effect of biatrial pacing in prevention of atrial fibrillation after coronary artery bypass grafting. Circulation 2000;102:1382\u20131387",
            "year": 2000
        },
        {
            "authors": [
                "EP Gerstenfeld",
                "M Khoo",
                "RC. Martin"
            ],
            "title": "Effectiveness of bi-atrial pacing for reducing atrial fibrillation after coronary artery bypass graft surgery",
            "venue": "J Interv Card Electrophysiol",
            "year": 2001
        },
        {
            "authors": [
                "Y Ruan",
                "NB Robinson",
                "A. Naik"
            ],
            "title": "Effect of atrial pacing on post-operative atrial fibrillation following coronary artery bypass grafting: pairwise and network meta-analyses",
            "venue": "Int J Cardiol 2020;302:103\u2013107",
            "year": 2019
        },
        {
            "authors": [
                "T Xiong",
                "L Pu",
                "Y-F Ma",
                "Y-L Zhu",
                "H Li",
                "X Cui"
            ],
            "title": "Posterior pericardiotomy to prevent new-onset atrial fibrillation after coronary artery bypass grafting: a systematic review and meta-analysis of 10 randomized controlled trials",
            "venue": "J Cardiothorac Surg 2021;16:233",
            "year": 2021
        },
        {
            "authors": [
                "S Liu",
                "Y Jing",
                "J Zhang",
                "C Bian",
                "YU Zhang",
                "X. Zhang"
            ],
            "title": "Does anterior fat pad removal reduce the incidence of atrial fibrillation after CABG? A meta-analysis of randomized controlled trials",
            "venue": "Pacing Clin Electrophysiol 2015;38:1363\u20131368",
            "year": 2015
        },
        {
            "authors": [
                "E Pokushalov",
                "B Kozlov",
                "A Romanov",
                "A Strelnikov",
                "S Bayramova",
                "D Sergeevichev"
            ],
            "title": "Botulinum toxin injection in epicardial fat pads can prevent recurrences of atrial fibrillation after cardiac surgery: results of a randomized pilot study",
            "venue": "J Am Coll Cardiol",
            "year": 2014
        },
        {
            "authors": [
                "JP Piccini",
                "A Ahlsson",
                "P Dorian",
                "MA Gillinov",
                "PR Kowey",
                "MJ Mack"
            ],
            "title": "Design and rationale of a phase 2 study of NeurOtoxin (botulinum toxin type A) for the PreVention of post-operative atrial fibrillation\u2014the NOVA study",
            "venue": "Am Heart J 2022;245:51\u201359",
            "year": 2021
        },
        {
            "authors": [
                "T Al-Atassi",
                "H Toeg",
                "T Malas",
                "BK. Lam"
            ],
            "title": "Mapping and ablation of autonomic ganglia in prevention of postoperative atrial fibrillation in coronary surgery: MAAPPAFS atrial fibrillation randomized controlled pilot study",
            "venue": "Can J Cardiol 2014;30:1202\u20131207",
            "year": 2014
        },
        {
            "authors": [
                "B Kiaii",
                "S Fox",
                "L Chase",
                "M Fernandes",
                "LW Stitt",
                "R Guo"
            ],
            "title": "Postoperative atrial fibrillation is not pulmonary vein dependent: results from a randomized trial",
            "venue": "Heart Rhythm 2015;12:699\u2013705",
            "year": 2015
        },
        {
            "authors": [
                "SM Al-Khatib",
                "G Hafley",
                "RA. Harrington"
            ],
            "title": "Patterns of management of atrial fibrillation complicating coronary artery bypass grafting: results from the PRoject of ex-vivo vein graft ENgineering via transfection IV (PREVENT-IV) trial",
            "venue": "Am Heart J 2009;158:",
            "year": 2009
        },
        {
            "authors": [
                "JK Lee",
                "GJ Klein",
                "AD Krahn",
                "R Yee",
                "K Zarnke",
                "C Simpson"
            ],
            "title": "Rate-control versus conversion strategy in postoperative atrial fibrillation: trial design and pilot study results",
            "venue": "Card Electrophysiol Rev 2003;7:178\u2013184",
            "year": 2003
        },
        {
            "authors": [
                "AM Gillinov",
                "E Bagiella",
                "AJ Moskowitz",
                "JM Raiten",
                "MA Groh",
                "ME Bowdish"
            ],
            "title": "Rate control versus rhythm control for atrial fibrillation after cardiac surgery",
            "venue": "N Engl J Med",
            "year": 1602
        },
        {
            "authors": [
                "AP Carnicelli",
                "H Hong",
                "SJ. Connolly"
            ],
            "title": "Direct oral anticoagulants versus warfarin in patients with atrial fibrillation: patient-level network meta-analyses of randomized clinical trials with interaction testing by age and sex. Circulation 2022;145:242\u2013255",
            "venue": "https://doi. org/10.1161/CIRCULATIONAHA.121.056355",
            "year": 2022
        },
        {
            "authors": [
                "RG Hart",
                "O Benavente",
                "R McBride",
                "LA. Pearce"
            ],
            "title": "Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis",
            "venue": "Ann Intern Med",
            "year": 1999
        },
        {
            "authors": [
                "CT January",
                "LS Wann",
                "JS Alpert",
                "H Calkins",
                "JE Cigarroa",
                "JC Cleveland"
            ],
            "title": "AHA/ ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society",
            "venue": "J Am Coll Cardiol 2014;64:e1\u201376",
            "year": 2014
        },
        {
            "authors": [
                "JH Butt",
                "Y Xian",
                "ED Peterson",
                "PS Olsen",
                "R R\u00f8rth",
                "A Gundlund"
            ],
            "title": "Long-term thromboembolic risk in patients with postoperative atrial fibrillation after coronary artery bypass graft surgery and patients with nonvalvular atrial fibrillation",
            "venue": "JAMA Cardiol 2018;3:417\u2013424",
            "year": 2018
        },
        {
            "authors": [
                "FS Riad",
                "M Grau-Sepulveda",
                "OK. Jawitz"
            ],
            "title": "Anticoagulation in new-onset postoperative atrial fibrillation: an analysis from the society of thoracic surgeons adult cardiac surgery database",
            "venue": "Heart Rhythm",
            "year": 2022
        },
        {
            "authors": [
                "CT January",
                "LS Wann",
                "H Calkins",
                "LY Chen",
                "JE Cigarroa",
                "JC Cleveland"
            ],
            "title": "AHA/ ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/ American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society",
            "venue": "J Am Coll Cardiol",
            "year": 2019
        }
    ],
    "sections": [
        {
            "text": ". . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .\nPostoperative atrial fibrillation (POAF) is the most common type of secondary atrial fibrillation (AF) and despite progress in prevention and treatment, remains an important clinical problem for patients undergoing a variety of surgical procedures, and in particular cardiac surgery.\nPOAF significantly increases the duration of postoperative hospital stay, hospital costs, and the risk of recurrent AF in the years after surgery; moreover, POAF has been associated with a variety of adverse cardiovascular events (including stroke, heart failure, and mortality), although it is still unclear if this is due to causal relation or simple association.\nNew data have recently emerged on the pathophysiology of POAF, and new preventive and therapeutic strategies have been proposed and tested in randomized trials.\nThis review summarizes the current evidence on the pathogenesis, incidence, prevention, and treatment of POAF and highlights future directions for clinical research.\nKeywords Postoperative atrial fibrillation \u2022 Mechanisms \u2022 Treatment\nIntroduction Postoperative atrial fibrillation (POAF) is the most common type of secondary atrial fibrillation (AF) and the most common complication after cardiac surgery.1 POAF significantly increases in-hospital stay and costs and has been associated with a variety of adverse cardiovascular events (including stroke, heart failure, and mortality), although it is unclear if this is due to causal relation or simple association.2\u20134 POAF also significantly increases the risk of recurrent AF in the years after surgery.5,6\nIn the last decade, new data have emerged on the pathophysiology of POAF, and new preventive and therapeutic strategies have been proposed and tested in randomized clinical trials (RCTs) (Figure 1).\nWe provide a summary of the current evidence on the pathogenesis, incidence, prevention, and treatment of POAF and highlight future directions for clinical research. To facilitate the reader, each section starts with a textbox highlighting key concepts.\nDetails of the search strategy and study selection are provided in the Supplementary material online, Appendix.\nPOAF definition and incidence\nWhile POAF is generally defined as newly occurring AF immediately after surgery, there is no consensus on the details of its definition. Different authors have defined POAF either as postoperative AF requiring treatment7 (a definition that ignores patients with selfterminating arrhythmias and those with contraindications to treatment, estimated at approximately 9600/year in the USA8), any postoperative AF episode lasting >30 s,9 any postoperative new-onset AF,10 or postoperative AF lasting longer than 10 min.11\nAlthough POAF has been best studied after cardiac surgery, it is also a common and costly complication after non-cardiac surgery, such as thoracic and general surgery. Regardless of the type of surgical operation, patients who develop POAF have longer in-hospital and intensive care stays, higher hospital costs, and higher rates of both short- and long-term adverse cardiovascular events.6,12\u201317\nThe incidence of POAF has remained relatively stable over time, despite continued awareness of its impact on clinical outcomes, and a plethora of new and old preventative strategies.18,19\nPOAF incidence following cardiac surgery Overall, approximately 30% of cardiac surgical patients develop POAF.20 However, POAF occurs at different rates depending on the type of cardiac operation. The incidence of POAF is higher after valve replacement surgery (up to over 50%), and lower following coronary artery bypass grafting (CABG: 20% of the patients).20 Cohort studies reported an incidence of approximately 30% in patients undergoing aortic surgery,21 and higher rates in the case of the combined valve and CABG operations.12,22 POAF incidence after a heart transplant is low (\u223c4%), possibly due to denervation of the implanted heart and morphologically normal implanted left atrium.23\nThe variable spectrum of reported POAF incidence may be attributed to differences in the baseline risk profiles of the patients and details of the surgical intervention, but also to heterogeneity in postoperative rhythm monitoring, and POAF definition.11,24 For example, the use of continuous ECG monitoring has been associated with a higher rate of POAF when compared to the daily 12-lead electrocardiogram (ECG).25\nPOAF incidence following transcatheter structural heart interventions Available data on new-onset AF following transcatheter structural heart interventions are mostly limited to patients undergoing\n. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Incidence\nAfter cardiac surgery\n\u2022 Overall: \u223c30%\n\u2022 CABG: \u223c20%\n\u2022 Valve surgery: 40%\u201350%\n\u2022 Aortic surgery: \u223c30%\n\u2022 Heart transplant: \u223c4%\nAfter thoracic surgery\n\u2022 Overall: \u223c15%\n\u2022 Pneumonectomy: \u223c30%\nAfter other types of surgery\n\u2022 0.4%\u201315%\nPOAF mechanisms and treatment 1021 D\now nloaded from https://academ ic.oup.com /eurheartj/article/44/12/1020/7017633 by Indian Institute of Technology Patna user on 13 January 2024\ntranscatheter aortic valve replacement (TAVR). In the PARTNER (Placement of Aortic Transcatheter Valve) 3 trial, in-hospital POAF occurred in 4.3% vs. 36.6% of TAVR vs. surgical aortic valve replacement (SAVR) patients, respectively (P < 0.0001).26\nIn the published series, POAF incidence after TAVR ranges between 1% and 32%,27\u201329 with higher rates after transapical vs. transfemoral procedures (6%\u201338% and 1%\u201316%, respectively).29\u201331\nPOAF incidence following thoracic surgery POAF is relatively frequent after thoracic surgery, although its incidence is lower on average (10%\u201320%) compared to cardiac surgery, likely due to the better baseline cardiac status of non-cardiac surgical patients.20,32\u201335 More invasive operations such as pneumonectomy, lung transplant, and esophagectomy have a higher risk of POAF (around 30%) suggesting that the extent of the surgical trauma may play a pathogenetic role.33,36\nPOAF incidence following other types of surgery The incidence of POAF after non-cardiac and non-thoracic surgery is lower, ranging from 0.4% to 15%.37\u201344 In a large cohort study (80 653 779 patients of whom 294 112 developed POAF),44 cesarean section had the lowest risk of POAF occurrence, while colorectal surgery had the highest.\nIn a retrospective analysis of administrative data of 370 447 adult patients undergoing major non-cardiac surgery at 375 US hospitals,42 10 957 (3.0%) developed clinically significant POAF, of which 7355 (67%) had a history of previous AF episodes.\nPOAF pathophysiology\nThe majority of the information on the pathophysiology of POAF is derived from the cardiac surgery series. The pathophysiology of POAF after cardiac surgery is unique relative to AF outside the perioperative period (non-surgical AF). While cardiovascular risk factors and comorbidity burden contribute to the risk of POAF, cardiac surgery imposes a unique set of circumstances that might facilitate POAF occurrence, including direct injury to the atrial myocardium, such as venous cannulation via right atriotomy or manipulation and suturing of the perivalvular atrial tissue in mitral and tricuspid surgery. Myocardial injury leads to inhomogeneity of conduction and anisotropic conduction which in turn favor dynamic re-entry and POAF.45\nInflammation is a key mechanism that promotes POAF. Peak concentrations of inflammatory markers like C-reactive protein occur at the\nFigure 1 Number of articles on POAF published each year between 1960 and 2021.\n. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Main pathophysiological theories \u2022 Atrial structural alterations\n\u2022 Pericardial effusion and inflammation\n\u2022 Gap junction uncoupling\n\u2022 Peri-atrial adipose tissue metabolic activity\n\u2022 Myocardial ischemia\n\u2022 Ion channels modifications\n\u2022 Autonomic neuromodulation\n\u2022 Re-entry and ectopic activity in the pulmonary veins\n1022 M. Gaudino et al. D\now nloaded from https://academ ic.oup.com /eurheartj/article/44/12/1020/7017633 by Indian Institute of Technology Patna user on 13 January 2024\nsame time as the peak incidence of POAF.46 The ability of antiinflammatory interventions to reduce the risk of POAF highlights the critical role of inflammation in the development of this arrhythmia. Of note, corticosteroid and possibly colchicine therapy have been associated with significant reductions in the occurrence of POAF.47,48\nModels of sterile pericarditis highlight how inflammation in the pericardium can lead to the induction of atrial arrhythmias. Pre-clinical works suggest that activation of epicardial fibroblasts in the atrium leads to the loss of epicardial myocytes and changes in connexins. Decreases in connexin 40 and 43 in the epicardium and midmyocardium lead to conduction slowing, which is non-uniform and proarrhythmic.49\nInterestingly, the application of gap junction modifiers improved conduction and prevented AF in a pre-clinical model of pericarditis.50\nShed mediastinal blood that remains in the pericardial space also leads to oxidation and inflammation.51 Epicardial adipose tissue has been demonstrated to be a source of pro-inflammatory paracrine effects that increase the risk and severity of AF.52,53 The secretome of atrial epicardial adipose tissue appears to promote electrical changes that directly favor AF, including reduced conduction velocity and increased heterogeneity of conduction in cardiomyocytes.54 More recently, it has been observed that epicardial adipose-mediated interleukin (IL)-1\u03b2 secretion is significantly higher in those who develop POAF compared with those individuals who do not develop POAF.55 Proteomic and gene expression analysis of epicardial adipose tissue in individuals with and without POAF after CABG demonstrated associations of proteins involved in both inflammation and ion channel regulation with POAF.56 Epicardial adipose mediators of inflammation and altered conduction may represent an attractive therapeutic target for localized strategies to prevent POAF since it is easily accessible at the time of cardiac surgery. Also, strategies aimed at draining the pericardium after cardiac surgery have been shown to be highly effective in reducing the incidence of POAF.57\nMyocardial ischemia also plays an important role in the pathogenesis of POAF. Coronary obstruction in the atrial branches has been associated with the development of AF outside of surgery.58\nIschemia-reperfusion injury to the atrial myocardium during and after the cardioplegic arrest has also been implicated in the development of POAF.59 On-pump coronary artery bypass, which is associated with greater myocardial ischemia (and inflammation) is also associated with a higher risk of POAF than off-pump bypass.60\nWhile traditional risk factors and altered atrial substrate predispose to all forms of AF, the degree to which acute factors and traditional risk factors contribute to the development of POAF is not entirely clear. Advancing age and comorbidity burden are associated with the probability of POAF.19,61 On the other hand, while differences in ion channel activity and expression often underlie the development of non-surgical AF, it is not clear whether changes in ion channel activity and expression are critical for the induction of POAF. The aggregate evidence does not strongly support any key differences in intracellular calcium levels or potassium channel activity between patients with and without POAF.62,63\nAutonomic influences appear to be critical in the pathogenesis of both non-surgical AF and POAF.64\u201366 In particular, sympathetic activation seems to play an important role in the initiation of POAF and elevated catecholamine levels predict the onset of POAF.67,68 Sympathetic activity leads to increased calcium gradients and afterdepolarizations that can trigger arrhythmia, particularly in the presence of concomitant parasympathetic stimulation. Parasympathetic stimulation leads to shortening of atrial-effective refractory periods.69 For example, calcium-induced afterdepolarizations in the presence of acetylcholine have been shown to increase pulmonary vein firing.69 Outside of the\nperioperative setting, pulmonary vein ectopy is known to be an important trigger of AF, and isolation of the pulmonary veins with catheter ablation leads to significant reductions in recurrent AF.70\nGiven the important role that autonomic influences and sympathetic activation have in the development of POAF, it is not surprising that beta-blocker therapy is protective against POAF. Cardiac denervation reduces the risk of POAF.71,72 Similarly, suppression of epicardial ganglionated plexi with either injection of calcium chloride (irreversible injury) or botulinum toxin (reversible suppression) has been shown to decrease the risk and severity of POAF.72\u201374 As our understanding of the autonomic changes that induce POAF improves, so too will our ability to treat and prevent POAF.\nThe main pathophysiological theories for POAF are summarized in Figure 2.\nThe possible overlap in risk factors for POAF following cardiac vs. non-cardiac surgery is summarized in Figure 3.\nAssociation of POAF with adverse clinical events\nPOAF is usually an asymptomatic, self-terminating event occurring 2 to 4 days after surgery. However, the clinical relevance of POAF is not only due to the arrhythmic episode per se, but also to its association with increased short- and long-term complications, such as prolonged inhospital stay, stroke, myocardial infarction, heart failure, and mortality.\nPatients who develop POAF are generally older and with more complex comorbidities compared to those who do not develop the arrhythmia and the risk factors for POAF are often also risk factors for adverse cardiovascular events, complicating any attempt at defining causality. When unadjusted for confounders, POAF is strongly associated with increased morbidity and mortality.75 In most of the published series, the association holds true even after multivariable adjustments.75,76\nIt has been shown that gene expression changes suggestive of extracellular matrix structural atrial remodeling are associated with nonsurgical AF, but not with POAF.4 However, almost all patients (83%) with non-surgical AF also experience POAF,4,14 suggesting that while POAF and non-surgical AF are two separate entities with different underlying mechanisms, POAF could be an early predictor of the development of non-surgical AF in the years after surgery and may be the mediator of the association between POAF and adverse cardiovascular events (Figure 4).3,20\nClinical events associated with POAF following cardiac surgery In a cohort study using administrative claims data across 11 states in the USA including 76 536 cardiac surgical patients, there was a strong\n. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Adverse clinical events associated with POAF \u2022 Hospitalization for heart failure\n\u2022 Mortality\n\u2022 Stroke\n\u2022 Myocardial infarction\n\u2022 Non-surgical AF\nPOAF mechanisms and treatment 1023 D\now nloaded from https://academ ic.oup.com /eurheartj/article/44/12/1020/7017633 by Indian Institute of Technology Patna user on 13 January 2024\nand statistically significant association between POAF and hospitalization for heart failure (hazard ratio [HR] 1.33, 95% confidence interval [CI] 1.25\u20131.41).77 A meta-analysis of 57 studies and 246 340 patients found that POAF was associated with perioperative mortality (odds ratio [OR] 1.92, 95%CI 1.58\u20132.33), stroke (OR 2.17, 95% CI 1.90\u2013 2.49), myocardial infarction (OR 1.28, 95% CI 1.06\u20131.54), and acute renal failure (OR 2.74, 95% CI 2.42\u20133.11) as well as long-term mortality and stroke.78 In another meta-analysis of 32 studies (155 575 patients) long-term mortality was significantly higher in patients with POAF, even after adjusting for confounders (HR 1.25, 95% CI 1.2\u2013 1.3; P < 0.01); 1-year mortality was 6% vs. 4% (OR 1.69, 95% CI 1.1\u20132.6; P = 0.02), 5-year mortality was 15% vs. 10% (OR 1.6, 95% CI 1.52\u20131.68; P < 0.0001), and 10-year mortality was 29% vs. 23% (OR 1.51, 95% CI 1.43\u20131.60; P < 0.0001). Moreover, stroke occurred four times more frequently in patients with POAF (1% vs. 4%; OR 4.09, 95%CI 2.49\u20136.72; P < 0.00001).79 The risk of developing nonsurgical AF has been reported to be 8 times higher in patients who developed POAF.14\nThe economic impact of POAF is also relevant. In a sub analysis of the Veterans Affairs Randomized On/Off Bypass Follow-up Study including 2203 patients, adjusted first-year costs after CABG were $15 300 greater for patients with POAF.80 If extrapolated to the number of cardiac surgery operations and assuming the reported incidence of POAF the extra cost related to POAF could exceed $2 billion/year in the USA only.81,82\nClinical events associated with POAF following non-cardiac surgery In a study including 2 929 854 non-cardiac surgical patients, POAF was strongly associated with hospitalization for heart failure (HR 2.02, 95%CI 1.94\u20132.10).77 A meta-analysis of 28 studies (2 612 816 patients) found that POAF after non-cardiac surgery was associated with an increase in the risk of stroke of almost three-fold at 1-month (weighted mean 2.1% vs. 0.7%; OR 2.82, 95%CI 2.15\u20133.70; P < 0.001) and four-fold at 12-month follow-up (weighted mean 2.0% vs. 0.6%; OR 4.12, 95% CI 3.34\u20135.11; P < 0.001).36 POAF was associated with an increased risk of myocardial infarction (weighted mean 12.4% vs. 3.2%; OR 4.11, 95%CI 2.72\u20136.22;\nFigure 2 Summary of the main pathophysiological mechanisms underlying POAF.\n1024 M. Gaudino et al. D\now nloaded from https://academ ic.oup.com /eurheartj/article/44/12/1020/7017633 by Indian Institute of Technology Patna user on 13 January 2024\nP < 0.001) and with a three-fold increased risk of mortality at \u22651-year follow-up (weighted mean 14.2% vs. 5.0%; OR 3.36, 95%CI 2.13\u20135.31; P < 0.001).\nIn another meta-analysis of 35 studies (2 458 010 patients), POAF was more strongly associated with stroke in patients undergoing non-cardiac surgery (HR 2.00; 95%CI 1.70\u20132.35) than in patients undergoing cardiac surgery (HR 1.20; 95%CI 1.07\u20131.34).83 In a retrospective analysis of 370 447 patients undergoing major non-cardiac surgery,42 patients with POAF had higher mortality (adjusted OR 1.72, 95%CI 1.59\u20131.86; P < 0.001), longer length of stay (adjusted relative difference, + 24.0%, 95% CI +21.5% to +26.5%; P < 0.001), and higher costs (adjusted difference, +US$4,177, 95%CI +3764 to +4590; P < 0.001).\nIn patients who developed POAF after for non-cardiac surgery the incidence of non-surgical AF is approximately 18% within the first postoperative 1 year. The risk of stroke or death is similar between those who experience POAF after non-cardiac surgery and those who have non-surgical AF.43\nAmong patients who developed POAF following non-cardiac surgery procedures, those who underwent colon resections (OR 4.67, 95%CI 4.03\u20135.40), who had preoperative coagulopathy (OR 3.30, 95%CI 2.83\u20133.85), congestive heart failure (OR 2.08, 95%CI 1.81\u20132.40), and preoperative fluid and electrolyte disorders (OR 3.21, 95%CI 2.82\u20133.66) have the highest risk of death; elective procedures (OR 0.23, 95%CI 0.19\u20130.27) and female sex (OR 0.88, 95%CI 0.78\u20130.99) are associated with lower mortality rates among patients with POAF.44\nPOAF prevention\nBeta-blockers Perioperative beta-blockers are the mainstay for POAF prophylaxis in patients undergoing cardiac surgery, as recommended by international guidelines (Class of Recommendation I, Level of Evidence A in the 2020 European Society of Cardiology [ESC] guidelines for the diagnosis and management of AF).84 However, available data\nFigure 3 Overlap in risk factors for POAF following cardiac vs. noncardiac surgery.\n. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .\nStrategies for POAF prevention Strength of evidence\nMechanisms of action\n\u2022 Beta-blockers +++ - Antiadrenergic activity\n\u2022 Amiodarone +++ - Inhibition of the inward potassium current\n- Antiadrenergic activity - Calcium channel blockade - Sodium channel blockade\n\u2022 Sotalol ++ - Potassium channel blockade - Beta-adrenergic receptor\nblockade\n\u2022 Other antiarrhythmic drugs\n(+) - Calcium channel blockade - Sodium channel blockade - Potassium channel\nblockade\n\u2022 Magnesium (+) - Unclear (might act via calcium channel blockade)\n\u2022 Colchicine (+) - Anti-inflammatory properties\n\u2022 Statins \u2212 - Anti-inflammatory and antioxidant properties\n\u2022 Glucocorticoids \u2212 - Anti-inflammatory properties\n\u2022 Polyunsaturated fatty acids\n\u2212 - Unclear (might act via modulation of ion channel activity)\n\u2022 Overdrive atrial pacing\n++ - Reduced bradycardia - Reduced atrial ectopic\nbeat burden\n\u2022 Left posterior pericardiotomy\n++ - Reduced postoperative pericardial effusion\n\u2022 Botulinum toxin injection\n(+) - Autonomic blockade - Autonomic\nneuromodulation\n\u2022 Intraoperative epicardial fat removal\n(+) - Autonomic neuromodulation\n\u2022 Ganglionated plexi ablation\n(+) - Autonomic blockade - Autonomic\nneuromodulation\n\u2022 Pulmonary vein ablation\n(+) - Isolation of rapidly firing foci in or close to the pulmonary veins\nPOAF mechanisms and treatment 1025 D\now nloaded from https://academ ic.oup.com /eurheartj/article/44/12/1020/7017633 by Indian Institute of Technology Patna user on 13 January 2024\nshow that in clinical practice beta-blocker therapy has been limited by imperfect utilization and high rates of postoperative withdrawal (up to 25%).19\nIn a meta-analysis including 13 studies and 25 496 patients undergoing cardiac surgery, Kim et al.85 reported significantly lower rates of POAF in those receiving perioperative beta-blockers (OR 0.56, 95% CI 0.35\u20130.91 and OR 0.70, 95%CI 0.55\u20130.91 in randomized and nonrandomized studies, respectively). POAF reduction did not translate into improved clinical outcomes, as perioperative stroke and length of stay did not differ between groups. These findings are consistent with data from a Cochrane meta-analysis86 of 33 RCTs showing reduced POAF incidence in cardiac surgical patients randomized to betablockers (OR 0.33, 95%CI 0.26\u20130.43), with no effects on length of stay, stroke rate, or mortality. A significant reduction of POAF occurrence in patients receiving prophylactic beta-blockers was also reported in a meta-analysis of 10 RCTs (2556 total patients)87 (20% vs. 32.8% in control subjects; P < 0.001) that also found that carvedilol was the most effective beta-blocker for POAF prevention (55% RR reduction vs. metoprolol; P < 0.001).\nThe prophylactic us of beta-blockers in non-cardiac surgery has been associated with an increase in serious postoperative adverse events and is discouraged by international guidelines (Class of Recommendation III harm, Level of Evidence B in the 2020 ESC guidelines for the diagnosis and management of AF).84 In an RCT involving 190 hospitals in 23 countries and a total of 8351 non-cardiac surgery patients randomized to receive metoprolol succinate immediately before surgery and then for 30 days or placebo, patients in the metoprolol group had lower risk of the composite of cardiovascular death, non-fatal myocardial infarction, and non-fatal cardiac arrest (5.8% vs. 6.9%; HR 0.84, 95%CI 0.70\u20130.99; P = 0.04) and of myocardial infarction (4.2% vs. 5.7%; HR 0.73, 95%CI 0.60\u20130.89; P = 0.001) but higher mortality (3.1% vs. 2.3%; HR 1.33, 95%CI\n1.03\u20131.74; P = 0.03) and stroke (1.0% vs. 0.5%; HR 2.17, 95%CI 1.26\u20133.74; P = 0.005).88 In a Cochrane review of 83 RCTs including 14 967 non-cardiac surgery patients,89 no significant differences between beta-blockers vs. control was found in postoperative mortality (risk ratio [RR] 1.17, 95%CI 0.89\u20131.54) and cerebrovascular events (RR 1.65, 95%CI 0.97\u20132.81), while lower incidence of myocardial infarction (RR 0.72, 95%CI 0.60\u20130.87) and postoperative AF or flutter (RR 0.41, 95%CI 0.21\u20130.79) were found in favor of beta-blockers.\nAmiodarone Amiodarone may exert beneficial effects in reducing POAF occurrence via multiple mechanisms, including, suppressing ectopic triggers as well as reentrant activity.90 The evidence for its use in cardiac surgical patients is derived from multiple RCTs; the largest was the PAPABEAR (Prophylactic Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, Valve Replacement, or Repair) trial (601 patients),91 where oral amiodarone led to a significant reduction in the incidence of postoperative atrial tachyarrhythmias (16.1% vs. 29.5%; HR 0.52; 95%CI 0.34\u2013 0.69; P < 0.001) compared to placebo, although no difference in postoperative complications or in-hospital death was reported. In a Cochrane metanalysis,86 amiodarone was found effective in reducing POAF incidence (OR 0.43, 95%CI 0.34\u20130.54) and length of hospital stay (\u22120.95 days, 95%CI \u22121.37 to \u22120.52 days) vs. placebo, without differences in stroke rate or mortality. In a meta-analysis of 14 RCTs and 2864 patients preoperative initiation of amiodarone was not more effective than postoperative administration in reducing POAF after cardiac surgery (OR 0.50, 95%CI 0.39\u20130.63 vs. OR 0.48, 95%CI 0.37\u20130.63 for preoperative and postoperative initiation, respectively; P = 0.86), but a total dose of 3000 mg or higher was more effective than lower doses.92\n1026 M. Gaudino et al. D\now nloaded from https://academ ic.oup.com /eurheartj/article/44/12/1020/7017633 by Indian Institute of Technology Patna user on 13 January 2024\nAmiodarone utilization is limited by risks of bradyarrhythmia, acute lung injury, and infusion-related hypotension.93 Acute lung injury, while rare, is more likely to occur under high oxygen tensions, common in ventilated patients post-cardiac surgery.94,95\nSotalol In a meta-analysis of 14 RCTs (5205 patients), sotalol significantly reduced the incidence of POAF following cardiac surgery compared with placebo (OR 0.37, 95%CI 0.29\u20130.48) and beta-blockers\nPOAF mechanisms and treatment 1027\n(OR 0.42, 95%CI 0.26\u20130.65).96 In the REDUCE trial, no significant differences in the risk of POAF was found among 160 cardiac surgical patients randomized to receive amiodarone or sotalol (17% vs. 25%, P = 0.21).97 Sotalol is renally cleared and may lead to QT prolongation, which make its use complex in cardiac surgery patients.20\nOther antiarrhythmic drugs Limited data are available on the use of other antiarrhythmic drugs for POAF prophylaxis.\nThe evidence supporting the use of calcium-channel blockers is weak.20,98 In a meta-analysis of 41 studies (3327 patients), calciumchannel blockers had no significant effect on the occurrence of postoperative supraventricular tachycardia in patients undergoing cardiac surgery (OR 0.73, 95%CI 0.48\u20131.12); at subgroup analysis nondihydropyridine agents reduced the incidence of the arrhythmias (OR 0.62, 95%CI 0.41\u20130.93), whereas dihydropyridine agents increased it (OR 2.69, 95%CI 0.57\u201312.64).98\nVery limited evidence is available on the use of class Ia, class Ic, or class III antiarrhythmic drugs (e.g.: procainamide, propafenone, and dofetilide). It is generally considered that antiarrhythmic drugs should be used with caution in the postoperative period, as their proarrhythmic adverse effects could be worsened in the setting of myocardial ischemia, concomitant inotropes administration, electrolyte disorders, hemodynamic instability, and abnormal liver and/or renal function.20\nMagnesium Conflicting data exist on the efficacy of intravenous magnesium for POAF prophylaxis.99,100 In an RCT of 389 cardiac surgery patients randomized to receive magnesium as a 50 mg/kg bolus immediately after induction of anesthesia followed by another 50 mg/kg infusion over 3 h magnesium did not reduce the incidence of POAF compared with placebo.101 In a meta-analysis of 20 small to mediumsized RCTs (2490 patients), magnesium administration was associated with a lower incidence of POAF (OR 0.54, 95%CI 0.38\u20130.75), with no effects on in-hospital length of stay or mortality.102 Similar results were reported in a Cochrane meta-analysis of 22 small- and medium-sized RCTs.86 However in a meta-analysis limited to five high-quality RCTs, magnesium administration was not associated with a significant reduction in POAF (OR 0.94, 95%CI 0.61\u20131.44; P = 0.77).103\nColchicine Current evidence supporting the use of colchicine for POAF prophylaxis is mixed. In the END-AF (Effect of Low-dose ColchiciNe on the InciDence of Atrial Fibrillation in Open Heart Surgery Patients) trial,104 low-dose colchicine did not prevent POAF in patients undergoing cardiac surgery (OR 0.85, 95%CI 0.37\u20131.99); the study was closed prematurely due to slow recruitment and had limited statistical power. However, in the Colchicine for the Prevention of the Post-Pericardiotomy Syndrome (COPPS) POAF substudy, 1-month colchicine reduced POAF incidence (12.0% vs. 22.0%; P = 0.021), in-hospital stay (9.4 \u00b1 3.7 vs. 10.3 \u00b1 4.3 days; P = 0.040) and rehabilitation stay (12.1 \u00b1 6.1 vs. 13.9 \u00b1 6.5 days; P = 0.009) after cardiac surgery.48\nThe ongoing COP-AF (Colchicine For The Prevention Of Perioperative Atrial Fibrillation In Patients Undergoing Thoracic\nSurgery) trial (NCT03310125; Table 2) will provide important information on the role of colchicine for POAF prevention.\nStatins, glucocorticoids, and polyunsaturated fatty acids Statins, glucocorticoids, and polyunsaturated fatty acids (PUFA) have been proposed for POAF prevention based on their anti-inflammatory (statins, glucocorticoids) and electrophysiological (PUFA) effects. However, available data on their efficacy are limited and current guidelines do not support their routine use.84\nOverdrive atrial pacing Overdrive atrial pacing has been shown to prevent POAF in multiple RCTs.105 In a Cochrane meta-analysis, Arsenault et al.86 reported that the incidence of POAF across 21 trials (2933 participants) was reduced from 32.8% in the non-paced group to 18.7% in the paced group (OR 0.47, 95%CI 0.36\u20130.61). In a small RCT of 118 patients, bi-atrial overdrive pacing for 96 h reduced the occurrence of POAF vs. standard therapy (OR 0.38, 95%CI 0.15\u20130.93).106 In a network meta-analysis of 14 RCTs (1727 patients) atrial pacing was associated with significantly lower incidence of POAF after CABG (OR 0.49, 95%CI 0.35\u20130.69) and bi-atrial pacing was associated with the largest risk reduction (OR 0.36, 95%CI 0.20\u20130.64 vs. OR 0.59, 95%CI 0.34\u20131.02 for left-atrial and OR 0.64, 95%CI 0.38\u20131.07 for right-atrial pacing).107\nOverdrive atrial pacing is logistically difficult to implement in routine clinical practice and may interfere with patients\u2019 activities in the postoperative period; its adoption outside of dedicated studies has therefore been limited.\nLeft posterior pericardiotomy Left posterior pericardiotomy is a surgical procedure that allows drainage of the pericardium into the left pleural space. Several RCTs have tested the role of posterior pericardiotomy in reducing POAF incidence, most of them reporting a significant effect; however, the methodologic quality of the RCTs was generally medium or low.2 In a meta-analysis of 10 RCTs including a total of 1829 CABG patients, the incidence of POAF was significantly reduced in the posterior pericardiotomy group (RR 0.45, 95%CI 0.29\u20130.64; P < 0.0001).108 The effects of posterior pericardiotomy were recently assessed in a well-powered, single-center RCT confirming that the intervention largely and significantly reduced the incidence of POAF (17% vs. 32%; P < 0.001; OR: 0.44, 95%CI 0.27\u20130.70; P < 0.001).9\nBotulinum toxin injection, intraoperative epicardial fat removal, ganglionated plexi, and pulmonary vein ablation Autonomic regulation and paracrine secretion of adipokines and cytokines mediated by peri-atrial fat play an important role in the modulation of atrial rhythm. However, current evidence suggests that anterior fat pad removal is not associated with decreased risk of POAF, as reported in a meta-analysis of seven RCTs including 991 CABG patients (RR 1.34, 95%CI 0.88\u20132.03; P = 0.18).109\nBotulinum toxin injection for POAF prevention has shown promising results in animal models and in a small RCT including 60 CABG patients with a history of paroxysmal AF (POAF incidence: 7% vs. 30% in the intervention group vs. controls, respectively; P = 0.024).110 The upcoming results of the NOVA trial (NCT03779841)111 and of the ongoing\n1028 M. Gaudino et al. D\now nloaded from https://academ ic.oup.com /eurheartj/article/44/12/1020/7017633 by Indian Institute of Technology Patna user on 13 January 2024\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ...\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ...\n.. ..\n... ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ...\n.. ..\n.. ..\n.. ..\n.. ..\n... ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n... ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. .\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. .\nT ab\nle 2\nM\nai n\non go\nin g\nra nd\nom iz\ned c\nlin ic\nal t\nri al\ns on\np re\nve nt\nio n\nan d\nm an\nag em\nen t\nof p\nos to\npe ra\nti ve\na tr\nia l fi\nbr ill\nat io\nn\nSt ud\ny na\nm e/\nT it\nle D\nes ig\nn n\nA im\n(s )\nP op\nul at\nio n\nIn te\nrv en\nti on\n(s )\nP ri\nm ar\ny ou\ntc om\ne( s)\nC A\nR D\nIA C\nS U\nR G\nER Y\nP A\nT IE\nN T\nS\nP O\nA F\npr ev\nen ti\non\nA ss\nes sm\nen t\nof In\ntr aO\npe ra\ntiv e\nA tr\nia l\nFi br\nilla tio\nn In\ndu ci\nbi lit\ny A\ns a\nSc re\nen in g To ol t o Pr ev en t Po st O pe ra tiv e A tr\nia l\nFi br\nilla tio\nn W\nith P\nro ph\nyl ax is A m io da ro ne (N C T0 38 68\n15 0)\nA llo\nca tio\nn: R\nan do\nm iz\ned\nIn te\nrv en\ntio n\nM od\nel :\nPa ra\nlle l A\nss ig\nnm en t In te rv en tio n M as ki\nng :\nN on\ne (O\npe n\nLa be\nl)\n60 0\nTo e\nva lu\nat e\nth e\nef fe\nct s o\nf a m\nio da\nro ne\no n\npa tie\nnt s\nw ith\nin du\nci bl\ne A\nF in\nr ed\nuc in g PO A F in ci de nc e\nPa tie\nnt s\nun de\nrg oi\nng fi\nrs t\ntim e\nca rd\nia c\nsu rg\ner y\nU se\no f p\nro ph\nyl ac\ntic a\nm io\nda ro\nne v s. st an da rd o f c ar e in p at ie nt s w ith in du\nci bl e A F (a s sc re en ed b y ra pi d at ria l p ac in g pr io r to in iti at io n of c ar di op ul m on ar y by pa ss )\nIn ci\nde nc\ne of\nP O\nA F\nLA N\nD I-P\nO A\nF (L\nan di\nol ol\nfo r\nPr ev\nen tio n of P os to pe ra tiv e A tr ia l F ib ril la tio n in Pa tie nt s U nd er go in g C ar di ac S ur ge ry ) (N C T0 50 84 11 8)\nA llo\nca tio\nn: R\nan do\nm iz\ned\nIn te\nrv en\ntio n\nM od\nel :\nPa ra\nlle l A\nss ig\nnm en t M as ki ng : Q ua dr up le (P ar tic ip an t, C ar e Pr ov id er , I nv es tig at or , O ut co m es A ss es so r)\n16 4\nTo e\nva lu\nat e\nw he\nth er\np os\nto pe\nra tiv e lo w -d os e la nd io lo l r ed uc es th e in ci\nde nc e of P O A F\nN on\n-A sia n pa tie nt s un de rg oi ng\nca\nrd ia\nc su\nrg er\ny\nU se\no f l\nan di\nol ol\nv s.\npl ac\neb o\nD ea\nth fr\nom a\nny r\nea so\nn or\nt he\noc\ncu rr\nen ce\no f P\nO A\nF\nPR EE\nM PT\nIV E\n(P re\nem pt\niv e\nPh ar\nm ac\nog en\net ic\n-g ui\nde d\nM et\nop ro\nlo l\nM an\nag em\nen t\nfo r\nPo st\nop er\nat iv\ne A\ntr ia l Fi br illa tio n in C ar di ac S ur ge ry ) (N C T0 39 43 92 7)\nA llo\nca tio\nn: N\n/A\nIn te\nrv en\ntio n\nM od\nel :\nSi ng\nle G\nro up\nA\nss ig\nnm en\nt M\nas ki\nng :\nN on\ne (O\npe n\nLa be\nl)\n40 0\nTo d\net er\nm in\ne th\ne ge\nno ty\npe o\nf C YP\n2D 6\nfo r\npa tie\nnt s\nun de\nrg oi\nng c\nar di\nac s\nur ge\nry ,\npr ov\nid e\nan a\nlte re\nd do\nsin g\nre co\nm m\nen da\ntio n\nfo r\nm et\nop ro\nlo l,\nan d\nre po\nrt t\nhe r\nel at\niv e\nef fe\nct iv\nen es\ns in\nm\nan ag\nin g\nPO A\nF fo\nr ea\nch\nph ar\nm ac\nog en\net ic\n-g ui\nde d\ndo sin\ng ca\nte go\nry\nPa tie\nnt s\nun de\nrg oi\nng\nca rd\nia c\nsu rg\ner y\nPh ar\nm ac\nog en\net ic\n-g ui\nde d\nm et\nop ro\nlo l\nm an\nag em\nen t\nIn ci\nde nc\ne of\nP O\nA F\nST O\nP_ A\nF (T\nra ns\ncu ta\nne ou\ns [T\nra gu\ns]\nVa ga\nl N er\nve S\ntim ul\nat io\nn fo\nr Po\nst -o p A fib ) ( N C T0 45 14 75 7)\nA llo\nca tio\nn: R\nan do\nm iz\ned\nIn te\nrv en\ntio n\nM od\nel :\nPa ra\nlle l A\nss ig\nnm en t M as ki ng : D ou bl e (P ar tic ip an t, O ut co\nm es\nA\nss es\nso r)\n26 6\nTo d\net er\nm in\ne th\ne va\nlu e\nof\ntr an\nsc ut\nan eo\nus (\ntr ag\nus ) v\nag us\nn er\nve\nst im\nul at\nio n\nin r\ned uc\nin g\nth e\nbu rd\nen o f PO A F an d da ys o f h os pi ta liz at io n af te r ca rd ia c su rg er y.\nPa tie\nnt s\nun de\nrg oi\nng\nca rd\nia c\nsu rg\ner y\nA ct\niv e\ntr an\nsc ut\nan eo\nus (t\nra gu\ns) v\nag us\nne\nrv e\nst im\nul at\nio n\nvs . s\nha m\nc on\ntr ol\nIn ci\nde nc\ne of\nP O\nA F\nC O\nC S\n(C O\nlc hi\nci ne\nin C\nar di\nac S\nur ge\nry )\n(N C\nT0 42\n24 54\n5) A\nllo ca\ntio n:\nR an\ndo m\niz ed\nIn\nte rv\nen tio\nn M\nod el : Pa ra lle l A ss ig nm en t M as ki ng : T rip le (P ar tic ip an t, C ar e Pr ov id er , I nv es tig at\nor )\n10 00\nTo s\ntu dy\nth e\nef fe\nct iv\nen es\ns of\ns ho\nrt -t\ner m\nad\nm in\nist ra\ntio n\nof c\nol ch\nic in\ne on\nP O\nA F\ntr ea\ntm en\nt\nPa tie\nnt s\nun de\nrg oi\nng\nca rd\nia c\nsu rg\ner y\nU se\no f c\nol ch\nic in\ne vs\n. p la\nce bo\nIn ci\nde nc\ne of\nP O\nA F\nLA N\nD IP\nRO TE\nC (P\nre ve\nnt io\nn of\nA tr\nia l\nFi br\nilla tio\nn by\nL ow\n-d os\ne La\nnd io\nlo l\nA llo\nca tio\nn: R\nan do\nm iz\ned\nIn te\nrv en\ntio n\nM od\nel :\nPa ra\nlle l A\nss ig\nnm en\nt\n40 0\nTo e\nva lu\nat e\nw he\nth er\nla nd\nio lo l po st op er at iv e in fu sio n is as so ci at ed\nw ith\nlo\nw er\nin ci\nde nc\ne of\nP O\nA F\nw ith\nou t e\nxc es\ns\nN on\n-A sia n pa tie nt\ns U\nse o\nf l an\ndi ol\nol v\ns. pl\nac eb\no In\nci de\nnc e\nof P\nO A\nF C on\ntin ue\nd POAF mechanisms and treatment 1029 D\now nloaded from https://academ ic.oup.com /eurheartj/article/44/12/1020/7017633 by Indian Institute of Technology Patna user on 13 January 2024\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ...\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ...\n.. ..\n... ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ...\n.. ..\n.. ..\n.. ..\n.. ..\n... ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n... ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. .\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. .\nT ab\nle 2\nC\non ti\nnu ed\nSt ud\ny na\nm e/\nT it\nle D\nes ig\nn n\nA im\n(s )\nP op\nul at\nio n\nIn te\nrv en\nti on\n(s )\nP ri\nm ar\ny ou\ntc om\ne( s)\nC A\nR D\nIA C\nS U\nR G\nER Y\nP A\nT IE\nN T\nS\nP O\nA F\npr ev\nen ti\non\nA dm\nin ist\nra tio\nn A\nfte r\nC ar\ndi ac\nS ur\nge ry ) (N C T0 46 07 12 2)\nM as\nki ng\n: Q ua\ndr up\nle\n(P ar\ntic ip\nan t,\nC ar e Pr ov id er , I nv es tig at\nor ,\nO ut\nco m\nes A\nss es\nso r)\nof a\ndv er\nse e\nve nt\ns as\nc om\npa re\nd to\nst\nan da\nrd o\nf c ar\ne un\nde rg\noi ng\nca\nrd ia\nc su\nrg er\ny\nBO TA\nF (P\nre ve\nnt io\nn A\ntr ia\nl F ib\nril la\ntio n\nby\nBO Tu\nlin um\nT ox\nin In\nje ct\nio ns ) (N C T0 40 75 98 1)\nA llo\nca tio\nn: R\nan do\nm iz\ned\nIn te\nrv en\ntio n\nM od\nel :\nPa ra\nlle l A\nss ig\nnm en t M as ki ng : T rip le\n(P\nar tic\nip an\nt, C\nar e\nPr ov\nid er\n, I nv\nes tig\nat or\n)\n22 0\nTo e\nva lu\nat e\nw he\nth er\nb ot\nul in\num t\nox in\nin\nje ct\nio n\nm ay\nr ed\nuc e\nPO A\nF du\nrin g\nth e\nfir st\np os\nto pe\nra tiv\ne m\non th\na fte\nr ca\nrd ia c su rg er y w ith ou t an y se rio us a dv er se ev en ts\nPa tie\nnt s\nun de\nrg oi\nng\nca rd\nia c\nsu rg\ner y\nBo tu\nlin um\nt ox\nin t\nyp e\nA in\ntr ao\npe ra\ntiv e\nin je\nct io\nn vs\n. p la\nce bo\nIn ci\nde nc\ne of\nP O\nA F\nEf fe\nct s o\nf L ef\nt A tr\nia l A\npp en\nda ge\nR es\nec tio n an d M ar sh al l L ig am en t A m pu ta tio n on C lin ic al O ut co m e in P at ie nt s U nd er go in g O ffpu m p C or on ar y A rt er y By pa ss (N C T0 42 20 04 7)\nA llo\nca tio\nn: R\nan do\nm iz\ned\nIn te\nrv en\ntio n\nM od\nel :\nPa ra\nlle l A\nss ig\nnm en t M as ki ng : D ou bl e (P ar tic ip an t, In ve st ig at or )\n40 0\nTo in\nve st\nig at\ne w\nhe th\ner su\nrg ic\nal o\ncc lu\nsio n\nof th\ne le\nft at\nria l a\npp en\nda ge\na nd\nM ar\nsh al l lig am en t am pu ta tio n du rin g of f-p um p C A BG is a ss oc ia te d w ith re du ce d ris ks o f PO A F an d st ro ke\nPa tie\nnt s\nun de\nrg oi\nng\nof f-p\num p\nC A\nBG\nLe ft\nat ria\nl a pp\nen da\nge r\nes ec\ntio n\nan d\nM ar\nsh al\nl L ig\nam en\nt am\npu ta\ntio n\nvs . n o in te rv en tio n\nIn ci\nde nc\ne of\nP O\nA F\nSa fe\nty a\nnd E\nffi ca\ncy o\nf T oc\not rie\nno ls\nin\nPo st\n-C A\nBG A\ntr ia\nl F ib\nril la\ntio n\n(N C\nT0 38\n07 03\n7)\nA llo\nca tio\nn: R\nan do\nm iz\ned\nIn te\nrv en\ntio n\nM od\nel :\nPa ra\nlle l A\nss ig\nnm en t M as ki ng : T rip le (P ar tic ip an t, In ve st ig at or , O ut co\nm es\nA\nss es\nso r)\n28 0\nTo e\nva lu\nat e\nth e\nef fe\nct s\nof\nsu pp\nle m\nen ta\ntio n\nw ith\nt oc\not rie\nno ls\nre du\nci ng\nt he\nin ci\nde nc\ne of\nA F\nPa tie\nnt s\nun de\nrg oi\nng\nC A\nBG\nU se\no f t\noc ot\nrie no\nls vs\n. p la\nce bo\nIn ci\nde nc\ne of\nP O\nA F\nTr aP\n-A F\n(T ra\ngu s\nSt im\nul at\nio n\nto P\nre ve\nnt\nA tr\nia l F\nib ril\nla tio\nn A\nfte r C\nar di\nac S\nur ge\nry )\n(N C\nT0 33\n92 64\n9)\nA llo\nca tio\nn: R\nan do\nm iz\ned\nIn te\nrv en\ntio n\nM od\nel :\nPa ra\nlle l A\nss ig\nnm en t M as ki ng : S in gl e (P ar tic ip an t)\n80 To\nd et\ner m\nin e\nw he\nth er\nt ra\ngu s\nst im\nul at\nio n\nin s\nub je\nct s\nun de\nrg oi\nng\nca rd\nia c\nsu rg\ner y\nle ad\ns to\ns ho\nrt er\noc\ncu rr\nen ce\ns, or\ne ve\nn pr\nev en\ntio n,\no f\nPO A\nF\nPa tie\nnt s\nun de\nrg oi\nng\nca rd\nia c\nsu rg\ner y\nTr ag\nus s\ntim ul\nat io\nn vs\n. s ha\nm c\non tr\nol Ti\nm e\nto t\nhe fi\nrs t\nep iso\nde o\nf A F\n> 30\ns E\nxt en\nde d\nho sp\nita liz\nat io\nn of\n>\n5 da\nys\nPa ra\nve rt\neb ra\nl B lo\nck t\no Re\ndu ce\nth e\nIn ci\nde nc\ne of\nN ew\nO ns\net A\ntr ia l Fi br illa tio n A fte r C ar di ac S ur ge\nry\n(N C\nT0 44\n72 29\n9)\nA llo\nca tio\nn: R\nan do\nm iz\ned\nIn te\nrv en\ntio n\nM od\nel :\nPa ra\nlle l A\nss ig\nnm en t M as ki ng : N on e (O pe n La be l)\n30 To\nd et\ner m\nin e\nif a\npe rio\npe ra\ntiv e\nin fu\nsio n\nof r\nop iv\nac ai\nne v\nia b\nila te\nra l T 3 pa ra ve rt eb ra l c at he te rs c an d ec re as\ne th e in ci de nc e of P O A F\nPa tie\nnt s\nun de\nrg oi\nng\nca rd\nia c\nsu rg\ner y\nPe rio\npe ra\ntiv e\nin fu\nsio n\nof r\nop iv\nac ai\nne v s. no in te rv en tio n\nIn ci\nde nc\ne of\nP O\nA F C\non tin\nue d 1030 M. Gaudino et al. D\now nloaded from https://academ ic.oup.com /eurheartj/article/44/12/1020/7017633 by Indian Institute of Technology Patna user on 13 January 2024\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ...\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ...\n.. ..\n... ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ...\n.. ..\n.. ..\n.. ..\n.. ..\n... ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n... ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. .\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. .\nT ab\nle 2\nC\non ti\nnu ed\nSt ud\ny na\nm e/\nT it\nle D\nes ig\nn n\nA im\n(s )\nP op\nul at\nio n\nIn te\nrv en\nti on\n(s )\nP ri\nm ar\ny ou\ntc om\ne( s)\nC A\nR D\nIA C\nS U\nR G\nER Y\nP A\nT IE\nN T\nS\nP O\nA F\npr ev\nen ti\non\nPU LV\nA B\n(R an\ndo m\niz ed\nC lin\nic al\nT ria l PU LV A B -P ro ph yl ac tic P ul m on ar y Ve in s A bl at io n) (N C T0 38 57 71 1)\nA llo\nca tio\nn: R\nan do\nm iz\ned\nIn te\nrv en\ntio n\nM od\nel :\nPa ra\nlle l A\nss ig\nnm en t M as ki ng : N on e (O pe n La be l)\n28 0\nTo c\nom pa\nre d\niff er\nen t P\nO A\nF pr\nop hy\nla ct\nic\nst ra\nte gi\nes : -\nG ro\nup I\n(c on\nve nt\nio na l C A BG ) - G ro up II (C A BG + pu lm on\nar y\nve in\ns iso\nla tio\nn) -\nG ro\nup II\nI ( C\nA BG + pu lm on ar y ve in s iso la tio n + am io da ro\nne )\n-G ro\nup IV\n(C A\nBG +\nam io\nda ro\nne )\nPa tie\nnt s\nun de\nrg oi\nng\nC A\nBG\n\u2212 G\nro up\nI (c\non ve\nnt io\nna l C\nA BG\n) - G\nro up\nII\n(C A\nBG +\npu lm\non ar\ny ve\nin s\niso la\ntio n) . C on co m ita nt C A BG a nd e pi ca rd ia l\nbi po\nla r\nra di\nof re\nqu en\ncy p\nul m\non ar\ny ve\nin s\niso la\ntio n.\nG ro\nup II\nI ( C\nA BG\n+ pu\nlm on\nar y\nve in\ns iso\nla tio\nn +\nam io\nda ro\nne ).\nC on\nco m\nita nt\nC A\nBG a\nnd e\npi ca\nrd ia l bi po la r ra di of re qu en cy p ul m on ar y ve in s ab la tio n w ith a dm in ist ra tio n of am io da ro ne in p os to pe ra tiv e pe rio d. -G ro up IV (C A BG + am io da ro ne ). C on ve nt io na l C A BG w ith a dm in ist ra tio n of a m io da ro ne in p os to pe ra tiv e pe rio d.\nIn ci\nde nc\ne of\nP O\nA F\nM aj\nor\nca rd\nio va\nsc ul\nar a\nnd c\ner eb\nra l e\nve nt\ns\nP O\nA F\nm an\nag em\nen t\nPA C\nES (A\nnt ic\noa gu\nla tio\nn fo\nr N\new -O\nns et\nPo\nst O\npe ra\ntiv e\nA tr\nia l F\nib ril\nla tio\nn A\nfte r\nC A\nBG ) (\nN C\nT0 40\n45 66\n5)\nA llo\nca tio\nn: R\nan do\nm iz\ned\nIn te\nrv en\ntio n\nM od\nel :\nPa ra\nlle l A\nss ig\nnm en t M as ki ng : N on e (O pe n La be l)\n32 00\nTo e\nva lu\nat e\nth e\nef fe\nct iv\nen es\ns an\nd sa\nfe ty\nof\na dd\nin g\nO A\nC t\no ba\nck gr\nou nd\nan\ntip la\nte le\nt th\ner ap\ny in\np at\nie nt\ns w\nith\nPO A\nF\nPa tie\nnt s\nun de\nrg oi\nng\niso la\nte d\nC A\nBG\nO A\nC in\na dd\niti on\nt o\nco nc\nom ita\nnt\nan tip\nla te\nle t\nth er\nap y\nvs . n\noO\nA C\nC om\npo sit\ne sc\nor e\nof d\nea th\n, s tr\nok e,\nTI\nA , M\nI, sy\nst em\nic a\nrt er\nia l\nth ro\nm bo\nem bo\nlis m\no r\nve no\nus\nth ro\nm bo\nem bo\nlis m\n(d ee\np ve\nno us\nth\nro m\nbo sis\na nd\n/o r\npu lm\non ar y em bo lis m ). A ny B A RC (B le ed\nin g\nA ca\nde m\nic R\nes ea\nrc h\nC on\nso rt\niu m ) ty pe 3 o r 5\nTA SK\n-P O\nA F\n(C os\ntef\nfe ct\niv en\nes s\nA na\nly sis\nBe\ntw ee\nn Tw\no A\nnt ic\noa gu\nla tio n St ra te gi es fo r A tr ia l F ib ril la tio\nn in\nt he\nPo\nst op\ner at\niv e\nPe rio\nd of\nC or\non ar y A rt er y By pa ss G ra ft Su rg er y) (N C T0 53 00 55 5)\nA llo\nca tio\nn: R\nan do\nm iz\ned\nIn te\nrv en\ntio n\nM od\nel :\nPa ra\nlle l A\nss ig\nnm en t M as ki ng : N on e (O pe n La be l)\n50 To\nc om\npa re\nt he\nc os\ntef\nfe ct\niv en\nes s\nre la\nte d\nto t\nhe w\nar fa\nrin p\nre sc\nrip tio n st ra te gy a ss oc ia te d w ith b rid ge\nan\ntic oa\ngu la\ntio n\nvs . t\nhe r\niv ar\nox ab\nan\npr es\ncr ip\ntio n\nin p\nat ie\nnt s\nw ith\nP O\nA F\nw ith\na\nm in\nim um\nd ur\nat io\nn of\n1 2\nh or\nA F\nth at\nre\nqu ire\ns in\nte rv\nen tio\nn.\nPa tie\nnt s\nun de\nrg oi\nng\nC A\nBG\nU se\no f r\niv ar\nox ab\nan v\ns. w\nar fa\nrin C\nos t-\nef fe\nct iv\nen es\ns of\nt he\ntr\nea tm\nen ts\nin b\not h\nth er\nap eu\ntic\ngr ou\nps (r\niv ar\nox ab\nan a\nnd w\nar fa\nrin )\nN EW\n-A F\n(R iv\nar ox\nab an\nv s.\nW ar\nfa rin\nfo r\nPo st\n-C ar\ndi ac\nS ur\nge ry\nA tr\nia l F\nib ril\nla tio\nn)\n(N C\nT0 37\n02 58\n2)\nA llo\nca tio\nn: R\nan do\nm iz\ned\nIn te\nrv en\ntio n\nM od\nel :\nPa ra\nlle l A\nss ig\nnm en t M as ki ng : S ta tis tic ia ns on ly\n30 0\nTo c\nom pa\nre t\nhe s\naf et\ny an\nd fin\nan ci\nal\nbe ne\nfit s\nof a\nrt er\nia l t\nhr om\nbo em\nbo lis\nm\npr op\nhy la\nxi s w\nith w\nar fa\nrin v\ns. riv\nar ox\nab an\nin\np at\nie nt\ns w\nith P\nO A\nF\nPa tie\nnt s\nun de\nrg oi\nng\nca rd\nia c\nsu rg\ner y\nU se\no f r\niv ar\nox ab\nan v\ns. w\nar fa\nrin Po\nst op\ner at\niv e\nle ng\nth o\nf s ta\ny\nCo nt\nin ue\nd POAF mechanisms and treatment 1031 D\now nloaded from https://academ ic.oup.com /eurheartj/article/44/12/1020/7017633 by Indian Institute of Technology Patna user on 13 January 2024\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ...\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ...\n.. ..\n... ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ...\n.. ..\n.. ..\n.. ..\n.. ..\n... ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n... ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. .\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. .\nT ab\nle 2\nC\non ti\nnu ed\nSt ud\ny na\nm e/\nT it\nle D\nes ig\nn n\nA im\n(s )\nP op\nul at\nio n\nIn te\nrv en\nti on\n(s )\nP ri\nm ar\ny ou\ntc om\ne( s)\nC A\nR D\nIA C\nS U\nR G\nER Y\nP A\nT IE\nN T\nS\nP O\nA F\npr ev\nen ti\non\nN O\nN -C\nA R\nD IA\nC S\nU R\nG ER\nY P\nA T\nIE N\nT S\nP O\nA F\npr ev\nen ti\non\nTh e\nEf fe\nct o\nf I nt\nra O\npe ra\ntiv e\nD ex\nm ed\net om\nid in\ne in\nP re\nve nt\nio n\nof\nEa rly\nP os\nto pe\nra tiv\ne A\ntr ia\nl F ib\nril la\ntio n\nin\nPa tie\nnt s\nU nd\ner go\nin g\nTh or\nac ic\nN\non -C\nar di\nac S\nur ge\nrie s:\na Ra\nnd om\niz ed\nC\non tr\nol le\nd Tr\nia l (\nN C\nT0 53\n20 70\n5)\nA llo\nca tio\nn: R\nan do\nm iz\ned\nIn te\nrv en\ntio n\nM od\nel :\nPa ra\nlle l A\nss ig\nnm en t M as ki ng : Q ua dr up le (P ar tic ip an t, C ar e Pr ov id er , I nv es tig at or , O ut co m es A ss es so r)\n35 0\nTo e\nva lu\nat e\nth e\nef fic\nac y\nof in\ntr ao\npe ra\ntiv e\nde xm\ned et\nom id\nin e\nin r\ned uc\nin g\nth e\nin ci\nde nc\ne of\nP O\nA F\nPa tie\nnt s\nun de\nrg oi\nng\nth or\nac ic\nno\nnca\nrd ia c su rg er y\nU se\no f i\nnt ra\nop er\nat iv\ne de\nxm ed\net om\nid in e vs . p la ce bo\nIn ci\nde nc\ne of\nP O\nA F\nC O\nPA\nF (C\nol ch\nic in\ne Fo\nr Th\ne Pr\nev en\ntio n\nO f P\ner io\npe ra\ntiv e\nA tr\nia l F\nib ril\nla tio\nn In\nPa\ntie nt\ns U\nnd er\ngo in\ng Th\nor ac\nic S\nur ge\nry )\n(N C\nT0 33\n10 12\n5)\nA llo\nca tio\nn: R\nan do\nm iz\ned\nIn te\nrv en\ntio n\nM od\nel :\nPa ra\nlle l A\nss ig\nnm en t M as ki ng : T rip le (P ar tic ip an t, In ve st ig at or , O ut co\nm es\nA\nss es\nso r)\n28 00\nTo a\nss es\ns w\nhe th\ner t\nhe a\ndm in\nist ra\ntio n\nof\nor al\nc ol\nch ic\nin e\nre du\nce s\nth e\nin ci\nde nc\ne of\nPO\nA F\nin p\nat ie\nnt s\nun de\nrg oi\nng m\naj or\nth\nor ac\nic s\nur ge\nry\nPa tie\nnt s\nun de\nrg oi\nng\nth or\nac ic\nsu\nrg er\ny\nU se\no f c\nol ch\nic in\ne vs\n. p la\nce bo\nIn ci\nde nc\ne of\nc lin\nic al\nly im\npo rt\nan t\nPO A\nF\nP O\nA F\nm an\nag em\nen t\nA SP\nIR E-\nA F\n(A nt\nic oa\ngu la\ntio n\nfo r\nSt ro\nke\nPr ev\nen tio\nn In\nP at\nie nt\ns W\nith R\nec en t Ep iso de s of P er io pe ra tiv e A tr ia l Fi br illa tio n A fte r N on -c ar di ac S ur ge\nry )\n(N C\nT0 39\n68 39\n3)\nA llo\nca tio\nn: R\nan do\nm iz\ned\nIn te\nrv en\ntio n\nM od\nel :\nPa ra\nlle l A\nss ig\nnm en t M as ki ng : S in gl e (O ut co m es A ss es so\nr)\n28 00\nTo a\nss es\ns th\ne ef\nfe ct\ns of\nN O\nA C\ns vs\n. n o\nan tic\noa gu\nla tio\nn on\nt he\nc o-\npr im\nar y\nco m\npo sit\ne ou\ntc om\nes o\nf ( i)\nno n-\nhe m\nor rh\nag ic\ns tr\nok e\nan d\nsy st\nem ic\nem\nbo lis\nm , a\nnd (i\ni) va\nsc ul\nar m\nor ta\nlit y,\na nd\nno\nnfa\nta l n\non -h\nem or\nrh ag\nic s\ntr ok\ne, M I, pe rip he ra l a rt er ia l t hr om bo sis , am pu ta tio n, a nd s ym pt om at ic v en ou s th ro m bo em bo lis m 2 4 m on th s af te r ra nd om iz at io n.\nPa tie\nnt s\nun de\nrg oi\nng\nno n-\nca rd\nia c\nsu rg\ner y\nU se\no f N\nO A\nC v\ns. no\na nt\nic oa\ngu la\ntio n\nIn ci\nde nc\ne of\nn on\n-h em\nor rh\nag ic\nst\nro ke\no r\nsy st\nem ic\ne m\nbo lis\nm\nIn ci\nde nc\ne of\nv as\ncu la\nr m or\nta lit\ny, a\nnd\nno n-\nfa ta\nl n on\n-h em\nor rh\nag ic\ns tr\nok e,\nM\nI, pe\nrip he\nra l a\nrt er\nia l t\nhr om\nbo sis , am pu ta tio n, a nd s ym pt om at ic ve no us t hr om bo em bo lis m\nSo ur\nce : C\nlin ic\nal tr\nia ls.\ngo v\n(a cc\nes se\nd: 1\n5 Se\npt em\nbe r\n20 22 ). A F, a tr ia l fi br illa tio n; C A BG , c or on ar y ar te ry b yp as s gr af\ntin g;\nM I,\nm yo\nca rd\nia l i\nnf ar\nct io\nn; N\nO A\nC , n\non -v\nita m\nin K\no ra\nl a nt\nic oa\ngu la\nnt s;\nO A\nC , o\nra l a\nnt ic\noa gu\nla nt\n; P O\nA F,\np os\nto pe\nra tiv\ne at\nria l fi\nbr illa\ntio n;\nT IA\n, t ra\nns ie\nnt is\nch em\nic a\ntt ac\nk. 1032 M. Gaudino et al. D\now nloaded from https://academ ic.oup.com /eurheartj/article/44/12/1020/7017633 by Indian Institute of Technology Patna user on 13 January 2024\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.\nT ab\nle 3\nSe\nle ct\ned s\ntu di\nes e\nva lu\nat in\ng m\nai n\nst ra\nte gi\nes fo\nr pr\nev en\nti on\no f p\nos to\npe ra\nti ve\na tr\nia l fi\nbr ill\nat io\nn\nSt ud\ny, y\nea r\nT yp\ne of\ns tu\ndy N\num be r of p at ie nt\ns Se\ntt in\ng T\nes te\nd in\nte rv\nen ti\non s\nP ri\nm ar\ny ou\ntc om\ne Fo\nllo w\n-u p\nM ai\nn re\nsu lt\ns\nK im\ne t\nal .,\n20 21\n85 M\net a-\nan al\nys is\n(fi ve\nra\nnd om\niz ed\na nd\ne ig\nht\nno n-\nra nd\nom iz\ned\nst ud\nie s)\n25 49\n6 C\nar di\nac\nsu rg\ner y\nBe ta\n-b lo\nck er\ns vs\n. p la\nce bo\nPO A\nF in\nci de\nnc e\nIn -h\nos pi\nta l\nst ay\nLo w\ner in\nci de\nnc e\nof P\nO A\nF in\nt he\nb et\nabl\noc ke r gr ou p (O R 0. 56 , 9 5% C I 0 .3 5\u2013 0. 91 a nd O R 0. 70 , 95 % C I 0 .5 5\u2013 0. 91 in r an do m iz ed a nd no nra nd om iz ed s tu di es , r es pe ct iv el y) . Pe rio pe ra tiv e st ro ke a nd le ng th o f s ta y di d no t di ffe r be tw ee n th e tw o gr ou ps .\nA rs\nen au lt et a l., 20 13 86\nC oc\nhr an\ne m\net a-\nan al\nys is\n(3 3\nRC Ts\n) 46\n98 C\nar di\nac\nsu rg\ner y\nBe ta\n-b lo\nck er\ns vs\n. p la\nce bo\nPO A\nF or\ns up\nra ve\nnt ric\nul ar\nta\nch yc\nar di\na in\nci de\nnc e\nIn -h\nos pi\nta l\nst ay\nLo w\ner in\nci de\nnc e\nof P\nO A\nF in\nt he\nb et\nabl\noc ke\nrs\ngr ou\np (O\nR 0.\n33 , 9\n5% C\nI 0 .2\n6\u2013 0.\n43 ).\nN o\nef fe\nct s\non le\nng th\no f s\nta y,\ns tr\nok e\nra te\no r\nm or\nta lit\ny.\nK ha\nn et\na l.,\n20 13\n87 M\net a-\nan al\nys is\n(1 0\nRC Ts\n) 25\n56 C\nar di\nac\nsu rg\ner y\nBe ta\n-b lo\nck er\ns vs\n. p la\nce bo\nPO A\nF in\nci de\nnc e\nIn -h\nos pi\nta l\nst ay\nLo w\ner in\nci de\nnc e\nof P\nO A\nF in\nt he\nb et\nabl\noc ke\nrs\ngr ou\np (2\n0% v\ns. 32\n.8 %\nin c\non tr\nol s\nub je\nct s;\nP <\n0.\n00 1)\n. C ar\nve di\nlo l w\nas t\nhe m\nos t\nef fe\nct iv e be ta -b lo ck er fo r PO A F pr ev en tio n (5 5% R R re du ct io n vs . m et op ro lo l; P < 0. 00 1) .\nPO IS\nE st\nud y,\n20\n08 88\nRC T\n83 51\nN on\n-c ar\ndi ac\nsu\nrg er\ny Be\nta -b\nlo ck\ner s\n(e xt\nen de\ndre\nle as e m et op ro lo l s uc ci na\nte ) v s. pl ac eb o\nC om\npo sit\ne of\nc ar\ndi ov\nas cu\nla r\nde at\nh, n\non -fa\nta l M\nI, an\nd no\nnfa\nta l\nca rd\nia c\nar re\nst\n30 -d\nay Lo\nw er\nin ci\nde nc\ne of\nb ot\nh th\ne pr\nim ar\ny co\nm po\nsit e\nen dp\noi nt\n(5 .8\n% v\ns. 6.\n9% ; H\nR 0.\n84 , 9\n5% C\nI 0 .7\n0\u2013\n0. 99\n, P =\n0. 04\n) a nd\no f M\nI ( 4.\n2% v\ns. 5.\n7% ; H\nR 0.\n73 ,\n95 %\nC I 0\n.6 0\u2013\n0. 89\n, P =\n0. 00\n1) in\nt he\nbe\nta -b\nlo ck\ner s\ngr ou\np. H\nig he\nr ra\nte s\nof d\nea th\n(3\n.1 %\nv s.\n2. 3%\n; H R\n1. 33\n, 9 5%\nC I 1\n.0 3\u2013\n1. 74\n, P =\n0.\n03 ) a\nnd st\nro ke\n(1 .0\n% v\ns. 0.\n5% ; H\nR 2.\n17 , 9\n5% C I 1. 26 \u20133 .7 4, P = 0. 00 5) w er e re po rt ed in t he be ta -b lo ck er s gr ou p.\nPA PA\nBE A R st ud y, 20 05 91\nRC T\n60 1\nC ar\ndi ac\nsu\nrg er\ny A\nm io\nda ro\nne v\ns. pl\nac eb\no In\nci de\nnc e\nof a\ntr ia l ta ch ya rr hy th m ia s la st in g\n5 m\nin\nor lo\nng er\nth at\np ro\nm pt\ned th\ner ap y by t he s ix th p os to pe ra tiv e da y.\n1 ye\nar Lo\nw er\nr at\nes o\nf p os\nto pe\nra tiv\ne at\nria l\nta ch\nya rr\nhy th\nm ia\ns in\nt he\na m\nio da\nro ne\ng ro\nup\n(1 6.\n1% v\ns. 29\n.5 %\n; H R\n0. 52\n; 9 5%\nC I 0\n.3 4\u2013\n0. 69\n; P\n< 0.\n00 1)\n. N o\ndi ffe\nre nc\nes b\net w\nee n\nth e\n2 gr\nou ps\nw\ner e\nre po\nrt ed\nin s\ner io\nus p\nos to\npe ra\ntiv e\nco m\npl ic\nat io\nns , i\nnho\nsp ita\nl m or\nta lit\ny, o r re ad m iss io n to t he h os pi ta l w ith in 6 m on\nth s\nof\ndi sc\nha rg\ne or\nin 1\n-y ea\nr m\nor ta\nlit y.\nA rs\nen au lt et a l., 20 13 86\nC oc\nhr an\ne m\net a-\nan al\nys is\n(3 3\nRC Ts\n) 54\n02 C\nar di\nac\nsu rg\ner y\nA m\nio da\nro ne\nv s.\npl ac\neb o\nPO A\nF or\ns up\nra ve\nnt ric\nul ar\nta\nch yc\nar di\na in\nci de\nnc e\nIn -h\nos pi\nta l\nst ay\nLo w\ner in\nci de\nnc e\nof P\nO A\nF (O\nR 0.\n43 , 9\n5% C I 0. 34 \u20130 .5 4) a nd le ng th o f h os pi ta l s ta y (\u2212 0. 95 da ys , 9 5% C I \u2212 1. 37 t o \u2212 0. 52 d ay s) in t he am io da ro ne g ro up . N o di ffe re nc es in s tr ok e ra te o r m or ta lit y be tw ee n th e tw o gr ou ps .\nCo nt\nin ue\nd POAF mechanisms and treatment 1033 D\now nloaded from https://academ ic.oup.com /eurheartj/article/44/12/1020/7017633 by Indian Institute of Technology Patna user on 13 January 2024\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.. ..\n.\nT ab\nle 3\nC\non ti\nnu ed\nSt ud\ny, y\nea r\nT yp\ne of\ns tu\ndy N\num be r of p at ie nt\ns Se\ntt in\ng T\nes te\nd in\nte rv\nen ti\non s\nP ri\nm ar\ny ou\ntc om\ne Fo\nllo w\n-u p\nM ai\nn re\nsu lt\ns\nA rs\nen au lt et a l., 20 13 86\nC oc\nhr an\ne m\net a-\nan al\nys is\n(2 1\nRC Ts\n) 29\n33 C\nar di\nac\nsu rg\ner y\nO ve\nrd riv\ne at\nria l p\nac in\ng vs . no p ac in g (n o di st in ct io n be tw ee n pa ci ng s ite s)\nPO A\nF or\ns up\nra ve\nnt ric\nul ar\nta\nch yc\nar di\na in\nci de\nnc e\nIn -h\nos pi\nta l\nst ay\nLo w\ner in\nci de\nnc e\nof P\nO A\nF in\nt he\np ac\nin g\ngr ou p (3 2. 8% in t he n op ac in g gr ou p vs . 1 8. 7% in t he pa ce d gr ou p (O R 0. 47 , 9 5% C I 0 .3 6\u2013 0. 61 ).\nRu an\ne t\nal .,\n20 20\n10 7\nPa irw\nise a\nnd n\net w\nor k\nm et\naan\nal ys\nis (1\n4 RC\nTs )\n17 27\nC ar\ndi ac\nsu\nrg er\ny O\nve rd\nriv e\nat ria\nl p ac\nin g\n(b i-a\ntr ia\nl, le\nftat\nria l,\nan d\nrig ht\n-a tr\nia l p\nac in\ng) v\ns. no\npa\nci ng\nPO A\nF in\nci de\nnc e\nIn -h\nos pi\nta l\nst ay\nC om\npa re\nd w\nith n\no pa\nci ng\n, a ny\nfo rm\no f a\ntr ia l pa ci ng w as s ig ni fic an tly a ss oc ia te d w ith lo w er\nin ci\nde nc\ne of\nP O\nA F\n(O R\n0. 49\n, 9 5%\nC I 0\n.3 5\u2013\n0. 69 ). Bi -a tr ia l p ac in g w as a ss oc ia te d w ith t he la rg es t ris k re du ct io n (O R 0. 36 , 9 5% C I 0 .2 0\u2013 0. 64 v s. O R 0. 59 , 9 5% C I 0 .3 4\u2013 1. 02 fo r l ef tat ria l a nd O R 0. 64 , 9 5% C I 0 .3 8\u2013 1. 07 fo r rig ht -a tr ia l p ac in g) .\nX io\nng e\nt al ., 20 21 10\n8 M\net a-\nan al\nys is\n(1 0\nRC Ts\n) 18\n29 C\nar di\nac\nsu rg\ner y\nLe ft\npo st\ner io r pe ric ar di ot om y\nvs . n o in te rv en tio n\nPO A\nF in\nci de\nnc e\nIn -h\nos pi\nta l\nst ay\nLo w\ner in\nci de\nnc e\nof P\nO A\nF in\nt he\np os\nte rio r pe ric ar di ot om y gr ou p (r isk r at io 0 .4 5, 9 5% C I 0. 29 \u20130 .6 4, P < 0. 00 01 ).\nPA LA\nC S\ntr ia l, 20 21 9\nRC T\n42 0\nC ar\ndi ac\nsu\nrg er\ny Le\nft po\nst er\nio r\npe ric\nar di\not om\ny vs\n. n o\nin te\nrv en\ntio n\nPO A\nF in\nci de\nnc e\nIn -h\nos pi\nta l\nst ay\nLo w\ner in\nci de\nnc e\nof P\nO A\nF in\nt he\np os\nte rio r pe ric ar di ot om y gr ou p (1 7% v s. 32 % ; P < 0.\n00 1;\nO\nR: 0\n.4 4,\n9 5%\nC I 0\n.2 7\u2013\n0. 70\n, P <\n0. 00\n1) .\nC I,\nco nfi\nde nc\ne in\nte rv\nal ; H\nR, h\naz ar\nd ra\ntio ; M\nI, m\nyo ca\nrd ia\nl i nf\nar ct\nio n;\nO R,\no dd\ns ra\ntio ; P\nO A\nF, p\nos to\npe ra\ntiv e\nat ria\nl fi br\nilla tio\nn; R\nC T,\nr an\ndo m\niz ed\nc lin\nic al\nt ria\nl.\n1034 M. Gaudino et al. D\now nloaded from https://academ ic.oup.com /eurheartj/article/44/12/1020/7017633 by Indian Institute of Technology Patna user on 13 January 2024\nBOTAF study (NCT04075981) are expected to shed more light on the role of this interesting strategy to prevent POAF (Table 2).\nThe effects of map-guided ablation of the ganglionated plexi have been tested in the Mapping and ablation of autonomic ganglia in prevention of POAF in coronary surgery trial, a pilot study that reported a 32% reduction in POAF incidence with mapping and ablation.112 More recently, Wang et al.73 reported a 63% reduction in POAF following CaCl2 injection into the four major atrial ganglionated plexi (P = 0.001).\nCurrent evidence suggests a little role for systematic pulmonary vein ablation for POAF prevention in cardiac surgical patients. In a study of 175 CABG patients randomized to undergo bilateral radiofrequency pulmonary vein ablation in addition to CABG or CABG alone (and in whom intraoperative pulmonary vein isolation was confirmed by the inability to\npace the heart via the pulmonary veins after the ablation) no difference in POAF incidence was seen between the groups (37.1% vs. 36.1%; P = 0.88).113 The ongoing PULVAB trial (NCT03857711) will provide more information on this strategy for POAF prophylaxis (Table 2).\nDetails of selected studies evaluating main strategies for POAF prevention are summarized in Table 3.9,85\u201388,91,107,108\nPOAF treatment Rate vs. rhythm control Treatment of POAF is highly variable, including the use of rate control, cardioversion, and antiarrhythmic medication.114 When POAF\nPOAF mechanisms and treatment 1035\n/eurheartj/article/44/12/1020/7017633 by Indian Institute of Technology Patna user on 13 January 2024\ncomplicates cardiac surgery, patients with hemodynamic instability require immediate cardioversion and restoration of sinus rhythm. In hemodynamically stable patients, POAF can be treated with rate or rhythm control. Recommended drugs for rate control are betablockers, calcium-channel blockers, or digoxin in patients with preserved left ventricular ejection fraction (LVEF), and beta-blockers or digoxin in patients with reduced LVEF. When pharmacologic cardioversion is attempted, Class IC or III antiarrhythmic drugs should be preferred in patients with normal LVEF, while amiodarone should be used in those with reduced LVEF.84\nPreviously, evidence to support rate or rhythm control has been limited and predominantly originated from observational studies. A pilot trial published in 2003 suggested the potential for the reduced inhospital length of stay with rhythm control.115 However, an RCT comparing rate vs. rhythm control in 523 patients with POAF after cardiac surgery (CABG, valve surgery, or both) conducted by the Cardiothoracic Surgical Trials Network found no evidence for superiority with either a rate control only or a rhythm control approach.116\nIn this RCT, rate control was predominantly achieved with betablockers (target heart rate: < 100 bpm) while rhythm control was performed with amiodarone (3 g load and 200 mg daily maintenance dose) and cardioversion, when necessary. At the end of the 60-day follow-up, there was no significant difference in in-hospital stay (P = 0.76), survival (P = 0.64), or serious adverse events (P = 0.61) between the two strategies. Notably, treatment deviation occurred in about 1 in 4 patients in both arms, highlighting the difficulties with these medications due to either ineffectiveness of rate control or adverse side effects with amiodarone. It is also important to note that the majority of patients were in sinus rhythm at discharge and at 60 days (94% in rate control and 98% in rhythm control), displaying the transient nature of POAF in most patients (acknowledging the high-rate of long-term recurrence). Thus, at present, managing hemodynamically stable POAF can be approached with either a rate or rhythm control strategy.\nStroke prevention The use of systemic oral anticoagulation in ambulatory patients with established AF is supported by a wealth of data from RCTs.117,118 In contrast, the use of oral anticoagulation to prevent stroke in patients with POAF is controversial and the evidence to support its use is mixed.\nAccording to current ESC guidelines, the use of long-term oral anticoagulation to prevent stroke is reasonable after POAF complicating noncardiac surgery (Class of Recommendation IIa, Level of Evidence B) and cardiac surgery (Class of Recommendation IIb, Level of Evidence B), given informed patient preferences.84\nSimilarly, current US guidelines recommend anticoagulation in patients who develop POAF (Class of Recommendation IIa, Level of Evidence B).119\nThe argument for oral anticoagulation in patients with POAF after cardiac surgery is based upon observational data that identify significantly increased odds of stroke in patients with POAF.83 Moreover, many patients with new-onset POAF will go on to develop established AF in follow-up. In one observational study, 50% of patients with POAF developed late AF, including 18% by 1 year.6 Some observational data have shown lower rates of stroke in those treated with oral anticoagulation. In a study including more than 10 000 patients (2108 with POAF after cardiac surgery), oral anticoagulation was associated with a lower risk of stroke (adjusted HR 0.55, 95%CI 0.32\u20130.95; P = 0.03).120\nHowever, a more recent analysis of 38 936 patients with POAF in the Society of Thoracic Surgeons Adult Cardiac Surgery Database found an association between discharge anticoagulation and increased mortality (HR 1.16, 95%CI 1.06\u20131.26).121 Furthermore, there was no apparent benefit with anticoagulation in those with CHA2DS2-VASc scores of 2\u20134 or \u22655.\nGiven these disparate data, it is unclear whether there is benefit or harm with oral anticoagulation after POAF. Data from ongoing large RCTS are awaited to provide clarity on this critically important question (NCT04045665; NCT03968393).\nCurrent recommendations for the management of POAF from the European and US guidelines are summarized in Table 4.84,119,122\nA summary of POAF epidemiology, pathophysiology, associated clinical events, prevention, and treatment strategies is provided in the Graphical Abstract.\nConclusions Despite progress in prevention and treatment, POAF remains an important clinical problem for patients undergoing a variety of surgical procedures, and in particular cardiac surgery. Classic preventive measures (such as the use of beta-blockers or amiodarone) have been shown to be highly effective and must be considered standard of care. For others (such as sequential atrial pacing), the adoption by the surgical community has been low despite good efficacy, due to logistic considerations. Recent progresses in our understanding of the pathophysiology of POAF have led to the introduction of new treatment strategies, aimed at draining the pericardial cavity after surgery or at locally suppressing parasympathetic activation, that has shown high efficacy in initial studies and must be tested in large confirmatory RCTs (details of the main ongoing RCTs are summarized in Table 2).\nFuture directions for clinical research The key gaps in current knowledge of POAF are summarized in Table 5. A key question that remains unanswered regards the nature of the association between POAF and subsequent adverse cardiovascular events. Future trials testing POAF prevention strategies should include a follow-up long enough to assess potential reductions in postoperative cardiovascular events associated with POAF reduction, as this is the ideal model to clarify if a casual association exists. Finally, it would be important to reach general consensus on a common definition of\n. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .\nTable 5 Main gaps in current knowledge of postoperative atrial fibrillation\nGaps in knowledge\nWhile POAF is generally defined as newly occurring AF immediately after surgery, there is no consensus on the details of its definition.\nThe mechanisms that initiate and sustain POAF are still not completely understood.\nWhile traditional risk factors and altered atrial substrate predispose to all forms of AF, the degree to which acute factors and traditional risk factors contribute to the development of POAF is not entirely clear.\nThe nature of the relationship between POAF and subsequent adverse cardiovascular events remains unclear (causal relation or association?).\nThe use of oral anticoagulation to prevent stroke in patients with POAF is controversial; current evidence to support its use is mixed.\nAF, atrial fibrillation; POAF, postoperative atrial fibrillation.\n1036 M. Gaudino et al.\nD\now nloaded from https://academ ic.oup.com /eurheartj/article/44/12/1020/7017633 by Indian Institute of Technology Patna user on 13 January 2024\nPOAF, to reduce heterogeneity and allow meaningful comparisons between studies.\nSupplementary data Supplementary data are available at European Heart Journal online.\nData availability The data underlying this article will be shared on reasonable request to the corresponding author.\nConflict of interest: Dr. Gaudino receives grant funding from the National Institutes of Health and the Canadian Institutes for Health and Research. Dr Di Franco has consulted for Servier, Novo Nordisk, and is an Advisory Board Member for Scharper. Michael Mack is a member of Steering Committee for AbbVie POAF Trial and Senior Vice President of CTSN Network. The other authors have no disclosures.\nFunding None.\nReferences 1. Lubitz SA, Yin X, Rienstra M, Schnabel RB, Walkey AJ, Magnani JW, et al. Long-term\noutcomes of secondary atrial fibrillation in the community: the Framingham Heart Study. Circulation 2015;131:1648\u20131655. https://doi.org/10.1161/CIRCULATIONAHA. 114.014058 2. Gaudino M, Di Franco A, Rong LQ, Cao D, Pivato CA, Soletti GJ, et al. Pericardial effusion provoking atrial fibrillation after cardiac surgery: JACC review topic of the week. J Am Coll Cardiol 2022;79:2529\u20132539. https://doi.org/10.1016/j.jacc.2022.04.029 3. van Boven WJ, de Groot JR, Kluin J. A short cut to prevent postoperative atrial fibrillation. Lancet Lond Engl 2021;398:2052\u20132053. https://doi.org/10.1016/S01406736(21)02435-1 4. van den Berg NWE, Neefs J, Kawasaki M, Nariswari FA, Wesselink R, Fabrizi B, et al. Extracellular matrix remodeling precedes atrial fibrillation: results of the PREDICT-AF trial. Heart Rhythm 2021;18:2115\u20132125. https://doi.org/10.1016/j.hrthm.2021.07.059 5. Lee SH, Kang DR, Uhm JS, Shim J, Sung JH, Kim JY, et al. New-onset atrial fibrillation predicts long-term newly developed atrial fibrillation after coronary artery bypass graft. Am Heart J 2014;167:593\u2013600.e1. https://doi.org/10.1016/j.ahj.2013.12.010 6. Melduni RM, Schaff HV, Bailey KR, Cha SS, Ammash NM, Seward JB, et al. Implications of new-onset atrial fibrillation after cardiac surgery on long-term prognosis: a community-based study. Am Heart J 2015;170:659\u2013668. https://doi.org/10.1016/j.ahj. 2015.06.015 7. Frendl G, Sodickson AC, Chung MK, Waldo AL, Gersh BJ, Tisdale JE, et al. 2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures. J Thorac Cardiovasc Surg 2014;148: e153\u2013e193. https://doi.org/10.1016/j.jtcvs.2014.06.036 8. Filardo G, Pollock BD, da Graca B, Phan TK, Sass DM, Ailawadi G, et al. Underestimation of the incidence of new-onset post-coronary artery bypass grafting atrial fibrillation and its impact on 30-day mortality. J Thorac Cardiovasc Surg 2017;154: 1260\u20131266. https://doi.org/10.1016/j.jtcvs.2017.05.104 9. Gaudino M, Sanna T, Ballman KV, Robinson NB, Hameed I, Audisio K, et al. Posterior left pericardiotomy for the prevention of atrial fibrillation after cardiac surgery: an adaptive, single-centre, single-blind, randomised, controlled trial. Lancet 2021;398: 2075\u20132083. https://doi.org/10.1016/S0140-6736(21)02490-9 10. Carter-Storch R, Dahl JS, Christensen NL, Pecini R, S\u00f8nderg\u00e5rd EV, \u00d8vrehus KA, et al. Postoperative atrial fibrillation after aortic valve replacement is a risk factor for longterm atrial fibrillation. Interact Cardiovasc Thorac Surg 2019;29:378\u2013385. https://doi.org/ 10.1093/icvts/ivz094 11. Zangrillo A, Landoni G, Sparicio D, Benussi S, Aletti G, Pappalardo F, et al. Predictors of atrial fibrillation after off-pump coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 2004;18:704\u2013708. https://doi.org/10.1053/j.jvca.2004.08.005 12. Greenberg JW, Lancaster TS, Schuessler RB, Melby SJ. Postoperative atrial fibrillation following cardiac surgery: a persistent complication. Eur J Cardiothorac Surg 2017;52: 665\u2013672. https://doi.org/10.1093/ejcts/ezx039 13. Steinberg BA, Zhao Y, He X, Hernandez AF, Fullerton DA, Thomas KL, et al. Management of postoperative atrial fibrillation and subsequent outcomes in contemporary patients undergoing cardiac surgery: insights from the Society of Thoracic Surgeons CAPS-Care Atrial Fibrillation Registry. Clin Cardiol 2014;37:7\u201313. https:// doi.org/10.1002/clc.22230 14. Ahlsson A, Fengsrud E, Bodin L, Englund A. Postoperative atrial fibrillation in patients undergoing aortocoronary bypass surgery carries an eightfold risk of future atrial\nfibrillation and a doubled cardiovascular mortality. Eur J Cardiothorac Surg 2010;37: 1353\u20131359. https://doi.org/10.1016/j.ejcts.2009.12.033 15. Fuller JA, Adams GG, Buxton B. Atrial fibrillation after coronary artery bypass grafting. Is it a disorder of the elderly? J Thorac Cardiovasc Surg 1989;97:821\u2013825. https://doi.org/ 10.1016/S0022-5223(19)34483-6 16. Lahtinen J, Biancari F, Salmela E, Mosorin M, Satta J, Rainio P, et al. Postoperative atrial fibrillation is a major cause of stroke after on-pump coronary artery bypass surgery. Ann Thorac Surg 2004;77:1241\u20131244. https://doi.org/10.1016/j.athoracsur.2003.09.077 17. Likosky DS, Caplan LR, Weintraub RM, Hartman GS, Malenka DJ, Ross CS, et al. Intraoperative and postoperative variables associated with strokes following cardiac surgery. Heart Surg Forum 2004;7:E271\u2013E276. https://doi.org/10.1532/HSF98. 20041035 18. Fernandez FG, Shahian DM, Kormos R, Jacobs JP, D\u2019Agostino RS, Mayer JE, et al. The society of thoracic surgeons national database 2019 annual report. Ann Thorac Surg 2019;108:1625\u20131632. https://doi.org/10.1016/j.athoracsur.2019.09.034 19. Mathew JP, Fontes ML, Tudor IC, Ramsay J, Duke P, Mazer CD, et al. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 2004;291:1720\u20131729. https:// doi.org/10.1001/jama.291.14.1720 20. Dobrev D, Aguilar M, Heijman J, Guichard J-B, Nattel S. Postoperative atrial fibrillation: mechanisms, manifestations and management. Nat Rev Cardiol 2019;16:417\u2013436. https://doi.org/10.1038/s41569-019-0166-5 21. Zhao R, Wang Z, Cao F, Song J, Fan S, Qiu J, et al. New-Onset postoperative atrial fibrillation after total arch repair is associated with increased in-hospital mortality. J Am Heart Assoc 2021;10:e021980. https://doi.org/10.1161/JAHA.121.021980 22. Akintoye E, Sellke F, Marchioli R, Tavazzi L, Mozaffarian D. Factors associated with postoperative atrial fibrillation and other adverse events after cardiac surgery. J Thorac Cardiovasc Surg 2018;155:242\u2013251. e10. https://doi.org/10.1016/j.jtcvs.2017. 07.063. 23. Vaseghi M, Boyle NG, Kedia R, Patel JK, Cesario DA, Wiener I, et al. Supraventricular tachycardia after orthotopic cardiac transplantation. J Am Coll Cardiol 2008;51: 2241\u20132249. https://doi.org/10.1016/j.jacc.2008.02.065 24. Tsai Y-T, Lai C-H, Loh S-H, Lin C-Y, Lin Y-C, Lee C-Y, et al. Assessment of the risk factors and outcomes for postoperative atrial fibrillation patients undergoing isolated coronary artery bypass grafting. Acta Cardiol Sin 2015;31:436\u2013443. https://doi.org/10. 6515/acs20150609a 25. Andrews TC, Reimold SC, Berlin JA, Antman EM. Prevention of supraventricular arrhythmias after coronary artery bypass surgery. A meta-analysis of randomized control trials. Circulation 1991;84:III236\u2013III244. 26. Shahim B, Malaisrie SC, George I, Thourani VH, Biviano AB, Russo M, et al. Postoperative atrial fibrillation or flutter following transcatheter or surgical aortic valve replacement: PARTNER 3 trial. JACC Cardiovasc Interv 2021;14:1565\u20131574. https://doi. org/10.1016/j.jcin.2021.05.026 27. Sannino A, Gargiulo G, Schiattarella GG, Perrino C, Stabile E, Losi MA, et al. A meta-analysis of the impact of pre-existing and new-onset atrial fibrillation on clinical outcomes in patients undergoing transcatheter aortic valve implantation. EuroIntervention 2016;12:e1047\u2013e1056. https://doi.org/10.4244/EIJY15M11_12 28. Gargiulo G, Capodanno D, Sannino A, Barbanti M, Perrino C, Capranzano P, et al. New-onset atrial fibrillation and increased mortality after transcatheter aortic valve implantation: a causal or spurious association? Int J Cardiol 2016;20:264\u2013266. https:// doi.org/10.1016/j.ijcard.2015.10.133 29. Tarantini G, Mojoli M, Urena M, Vahanian A. Atrial fibrillation in patients undergoing transcatheter aortic valve implantation: epidemiology, timing, predictors, and outcome. Eur Heart J 2017;38:1285\u20131293. https://doi.org/10.1093/eurheartj/ehw456 30. Motloch LJ, Reda S, Rottlaender D, Khatib R, M\u00fcller-Ehmsen J, Seck C, et al. Postprocedural atrial fibrillation after transcatheter aortic valve implantation versus surgical aortic valve replacement. Ann Thorac Surg 2012;93:124\u2013131. https://doi.org/ 10.1016/j.athoracsur.2011.08.078 31. J\u00f8rgensen TH, Thygesen JB, Thyregod HG, Svendsen JH, S\u00f8ndergaard L. New-onset atrial fibrillation after surgical aortic valve replacement and transcatheter aortic valve implantation: a concise review. J Invasive Cardiol 2015;271:41\u201347. 32. Amar D, Roistacher N, Burt M, Reinsel RA, Ginsberg RJ, Wilson RS. Clinical and echocardiographic correlates of symptomatic tachydysrhythmias after noncardiac thoracic surgery. Chest 1995;108:349\u2013354. https://doi.org/10.1378/chest.108.2.349 33. Vaporciyan AA, Correa AM, Rice DC, Roth JA, Smythe WR, Swisher SG, et al. Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients. J Thorac Cardiovasc Surg 2004;127:779\u2013786. https://doi.org/10.1016/j. jtcvs.2003.07.011 34. Passman RS, Gingold DS, Amar D, Lloyd-Jones D, Bennett CL, Zhang H, et al. Prediction rule for atrial fibrillation after major noncardiac thoracic surgery. Ann Thorac Surg 2005;79:1698\u20131703. https://doi.org/10.1016/j.athoracsur.2004.10.058 35. Merritt RE, Shrager JB. Prophylaxis and management of atrial fibrillation after general thoracic surgery. Thorac Surg Clin 2012;221:13\u201323. https://doi.org/10.1016/j.thorsurg. 2011.08.016 36. AlTurki A, Marafi M, Proietti R, Cardinale D, Blackwell R, Dorian P, et al. Major adverse cardiovascular events associated with postoperative atrial fibrillation after noncardiac\nPOAF mechanisms and treatment 1037 D\now nloaded from https://academ ic.oup.com /eurheartj/article/44/12/1020/7017633 by Indian Institute of Technology Patna user on 13 January 2024\nsurgery: a systematic review and meta-analysis. Circ Arrhythm Electrophysiol 2020;13: e007437. https://doi.org/10.1161/CIRCEP.119.007437 37. Polanczyk CA, Goldman L, Marcantonio ER, Orav EJ, Lee TH. Supraventricular arrhythmia in patients having noncardiac surgery: clinical correlates and effect on length of stay. Ann Intern Med 1998;129:279\u2013285. https://doi.org/10.7326/0003-4819-129-4-199808150-00003 38. Batra GS, Molyneux J, Scott NA. Colorectal patients and cardiac arrhythmias detected on the surgical high dependency unit. Ann R Coll Surg Engl 2001;83:174\u2013176. 39. Christians KK, Wu B, Quebbeman EJ, Brasel KJ. Postoperative atrial fibrillation in noncardiothoracic surgical patients. Am J Surg 2001;182:713\u2013715. https://doi.org/10.1016/ s0002-9610(01)00799-1 40. Walsh SR, Tang T, Wijewardena C, Yarham SI, Boyle JR, Gaunt ME. Postoperative arrhythmias in general surgical patients. Ann R Coll Surg Engl 2007;89:91\u201395. https://doi. org/10.1308/003588407X168253 41. Sohn GH, Shin D-H, Byun KM, Han HJ, Cho SJ, Song YB, et al. The incidence and predictors of postoperative atrial fibrillation after noncardiothoracic surgery. Korean Circ J 2009;39:100\u2013104. https://doi.org/10.4070/kcj.2009.39.3.100 42. Bhave PD, Goldman LE, Vittinghoff E, Maselli J, Auerbach A. Incidence, predictors, and outcomes associated with postoperative atrial fibrillation after major noncardiac surgery. Am Heart J 2012;164:918\u2013924. https://doi.org/10.1016/j.ahj.2012.09.004 43. Siontis KC, Gersh BJ, Weston SA, Jiang R, Roger VL, Noseworthy PA, et al. Associations of atrial fibrillation after noncardiac surgery with stroke, subsequent arrhythmia, and death: a cohort study. Ann Intern Med 2022;175:1065\u20131072. https://doi. org/10.7326/M22-0434 44. Prince-Wright LH, Akinyemi O, Nnorom SO, Bauer ES, Cornwell Iii EE, Fullum TM. Postoperative atrial fibrillation following non-cardiac surgery: predictors and risk of mortality. Am J Surg 2022;22:1062\u20131067. https://doi.org/10.1016/j.amjsurg.2022.07.010 45. Ishii Y, Schuessler RB, Gaynor SL, Yamada K, Fu AS, Boineau JP, et al. Inflammation of atrium after cardiac surgery is associated with inhomogeneity of atrial conduction and atrial fibrillation. Circulation 2005;111:2881\u20132888. https://doi.org/10.1161/ CIRCULATIONAHA.104.475194 46. Bruins P, Velthuis H, Yazdanbakhsh AP. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 1997;96: 3542\u20133548. https://doi.org/10.1161/01.cir.96.10.3542 47. Ho KM, Tan JA. Benefits and risks of corticosteroid prophylaxis in adult cardiac surgery: a dose-response meta-analysis. Circulation 2009;119:1853\u20131866. https://doi. org/10.1161/CIRCULATIONAHA.108.848218 48. Imazio M, Brucato A, Ferrazzi P. Colchicine reduces postoperative atrial fibrillation: results of the Colchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS) atrial fibrillation substudy. Circulation 2011;124:2290\u20132295. https://doi.org/ 10.1161/CIRCULATIONAHA.111.026153 49. Ryu K, Li L, Khrestian CM, Matsumoto N, Sahadevan J, Ruehr ML, et al. Effects of sterile pericarditis on connexins 40 and 43 in the atria: correlation with abnormal conduction and atrial arrhythmias. Am J Physiol Heart Circ Physiol 2007;293:H1231\u2013H1241. https:// doi.org/10.1152/ajpheart.00607.2006 50. Rossman EI, Liu K, Morgan GA. The gap junction modifier, GAP-134 [(2S,4R)-1-(2-aminoacetyl)-4-benzamido-pyrrolidine-2-carboxylic acid], improves conduction and reduces atrial fibrillation/flutter in the canine sterile pericarditis model. J Pharmacol Exp Ther 2009;329:1127\u20131133. https://doi.org/10.1124/jpet.108.150102 51. St-Onge S, Perrault LP, Demers P. Pericardial blood as a trigger for postoperative atrial fibrillation after cardiac surgery. Ann Thorac Surg 2018;105:321\u2013328. https://doi.org/10. 1016/j.athoracsur.2017.07.045 52. Wong CX, Sun MT, Odutayo A. Associations of epicardial, abdominal, and overall adiposity with atrial fibrillation. Circ Arrhythm Electrophysiol 2016;912:e004378. https://doi. org/10.1161/CIRCEP.116.004378 53. Wong CX, Ganesan AN, Selvanayagam JB. Epicardial fat and atrial fibrillation: current evidence, potential mechanisms, clinical implications, and future directions. Eur Heart J 2017;38:1294\u20131302. https://doi.org/10.1093/eurheartj/ehw045 54. Ernault AC, Verkerk AO, Bayer JD. Secretome of atrial epicardial adipose tissue facilitates reentrant arrhythmias by myocardial remodeling. Heart Rhythm 2022;19: 1461\u20131470. https://doi.org/10.1016/j.hrthm.2022.05.011 55. Cabaro S, Conte M, Moschetta D. Epicardial adipose tissue-derived IL-1beta triggers postoperative atrial fibrillation. Front Cell Dev Biol 2022;10:893729. https://doi.org/ 10.3389/fcell.2022.893729 56. Viviano A, Yin X, Zampetaki A. Proteomics of the epicardial fat secretome and its role in post-operative atrial fibrillation. Europace 2018;20:1201\u20131208. https://doi.org/10. 1093/europace/eux113 57. Gozdek M, Pawliszak W, Hagner W, Zalewski P, Kowalewski J, Paparella D, et al. Systematic review and meta-analysis of randomized controlled trials assessing safety and efficacy of posterior pericardial drainage in patients undergoing heart surgery. J Thorac Cardiovasc Surg 2017;153:865\u2013875.e12. https://doi.org/10.1016/j.jtcvs.2016.11.057 58. Pokorney SD, Berchuck SI, Chiswell K. Atrial branch coronary artery stenosis as a mechanism for atrial fibrillation. Heart Rhythm 2022;19:1237\u20131244. https://doi.org/ 10.1016/j.hrthm.2021.12.020 59. Tchervenkov CI, Wynands JE, Symes JF, Malcolm ID, Dobell AR, Morin JE. Persistent atrial activity during cardioplegic arrest: a possible factor in the etiology of\npostoperative supraventricular tachyarrhythmias. Ann Thorac Surg 1983;36:437\u2013443. https://doi.org/10.1016/S0003-4975(10)60484-5 60. Zhang P, Wang L, Zhai K. Off-pump versus on-pump redo coronary artery bypass grafting: a systematic review and meta-analysis. Perfusion 2021;36:724\u2013736. https:// doi.org/10.1177/0267659120960310 61. Burgos LM, Ramirez AG, Seoane L. New combined risk score to predict atrial fibrillation after cardiac surgery: COM-AF. Ann Card Anaesth 2021;24:458\u2013463. https://doi. org/10.4103/aca.ACA_34_20 62. Workman AJ, Pau D, Redpath CJ, Marshall GE, Russell JA, Kane KA, et al. Post-operative atrial fibrillation is influenced by beta-blocker therapy but not by preoperative atrial cellular electrophysiology. J Cardiovasc Electrophysiol 2006;17: 1230\u20131238. doi:10.1111/j.1540-8167.2006.00592.x 63. Dobrev D, Wettwer E, Kortner A, Knaut M, Schuler S, Ravens U. Human inward rectifier potassium channels in chronic and postoperative atrial fibrillation. Cardiovasc Res 2002;54:397\u2013404. https://doi.org/10.1016/S0008-6363(01)00555-7 64. Dimmer C, Tavernier R, Gjorgov N, Nooten G, Clement DL, Jordaens L. Variations of autonomic tone preceding onset of atrial fibrillation after coronary artery bypass grafting. Am J Cardiol 1998;82:22\u201325. https://doi.org/10.1016/S0002-9149(98)00231-8 65. Karatela MF, Fudim M, Mathew JP, Piccini JP. Neuromodulation therapy for atrial fibrillation. Heart Rhythm 2023;20:100\u2013111. https://doi.org/10.1016/j.hrthm.2022.08.011 66. Zimmermann M, Kalusche D. Fluctuation in autonomic tone is a major determinant of sustained atrial arrhythmias in patients with focal ectopy originating from the pulmonary veins. J Cardiovasc Electrophysiol 2001;12:285\u2013291. https://doi.org/10.1046/j.15408167.2001.00285.x 67. Amar D, Zhang H, Miodownik S, Kadish AH. Competing autonomic mechanisms precede the onset of postoperative atrial fibrillation. J Am Coll Cardiol 2003;42:1262\u20131268. https://doi.org/10.1016/S0735-1097(03)00955-0 68. Kalman JM, Munawar M, Howes LG. Atrial fibrillation after coronary artery bypass grafting is associated with sympathetic activation. Ann Thorac Surg 1995;60: 1709\u20131715. https://doi.org/10.1016/0003-4975(95)00718-0 69. Patterson E, Lazzara R, Szabo B. Sodium-calcium exchange initiated by the Ca2+ transient: an arrhythmia trigger within pulmonary veins. J Am Coll Cardiol 2006;47: 1196\u20131206. https://doi.org/10.1016/j.jacc.2005.12.023 70. Ha\u00efssaguerre M, Ja\u00efs P, Shah DC, Takahashi A, Hocini M, Quiniou G, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339:659\u2013666. https://doi.org/10.1056/NEJM199809033391003 71. Omran AS, Karimi A, Ahmadi H, Yazdanifard P, Sheikh Fahtollahi M, Tazik M. Prophylactic ventral cardiac denervation: does it reduce incidence of atrial fibrillation after coronary artery bypass grafting? J Thorac Cardiovasc Surg 2010;140:1036\u20131039. https://doi.org/10.1016/j.jtcvs.2009.12.024 72. Pokushalov E, Kozlov B, Romanov A, Strelnikov A, Bayramova S, Sergeevichev D, et al. Long-term suppression of atrial fibrillation by botulinum toxin injection into epicardial fat pads in patients undergoing cardiac surgery: one-year follow-up of a randomized pilot study. Circ Arrhythm Electrophysiol 2015;8:1334\u20131341. https://doi.org/10.1161/ CIRCEP.115.003199 73. Wang H, Zhang Y, Xin F, Jiang H, Tao D, Jin Y, et al. Calcium-induced autonomic denervation in patients with post-operative atrial fibrillation. J Am Coll Cardiol 2021;77: 57\u201367. https://doi.org/10.1016/j.jacc.2020.10.049 74. Waldron NH, Cooter M, Haney JC. Temporary autonomic modulation with botulinum toxin type A to reduce atrial fibrillation after cardiac surgery. Heart Rhythm 2019;16:178\u2013184. https://doi.org/10.1016/j.hrthm.2018.08.021 75. LaPar DJ, Speir AM, Crosby IK, Fonner E, Brown M, Rich JB, et al. Postoperative atrial fibrillation significantly increases mortality, hospital readmission, and hospital costs. Ann Thorac Surg. 2014;98:527\u2013533; discussion 533. https://doi.org/10.1016/j. athoracsur.2014.03.039 76. Benedetto U, Gaudino MF, Dimagli A, Gerry S, Gray A, Lees B, et al. Postoperative atrial fibrillation and long-term risk of stroke after isolated coronary artery bypass graft surgery. Circulation 2020;142:1320\u20131329. https://doi.org/10.1161/CIRCULATIONAHA.120. 046940 77. Goyal P, Kim M, Krishnan U, Mccullough SA, Cheung JW, Kim LK, et al. Post-operative atrial fibrillation and risk of heart failure hospitalization. Eur Heart J 2022;43: 2971\u20132980. https://doi.org/10.1093/eurheartj/ehac285 78. Caldonazo T, Kirov H, Rahouma M, Robinson NB, Demetres M, Gaudino M, et al. Atrial fibrillation after cardiac surgery: a systematic review and meta-analysis. J Thorac Cardiovasc Surg 2023;165:94\u2013103.e24. https://doi.org/10.1016/j.jtcvs.2021.03.077 79. Eikelboom R, Sanjanwala R, Le ML, Yamashita MH, Arora RC. Postoperative atrial fibrillation after cardiac surgery: a systematic review and meta-analysis. Ann Thorac Surg 2021;111:544\u2013554. https://doi.org/10.1016/j.athoracsur.2020.05.104 80. Almassi GH, Hawkins RB, Bishawi M, Shroyer AL, Hattler B, Quin JA, et al. New-onset postoperative atrial fibrillation impact on 5-year clinical outcomes and costs. J Thorac Cardiovasc Surg 2021;161:1803\u20131810.e3. https://doi.org/10.1016/j.jtcvs.2019.10.150 81. Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, et al. Heart disease and stroke statistics\u20132007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007;115:e69\u2013171. https://doi.org/10.1161/CIRCULATIONAHA.106.179918\n1038 M. Gaudino et al. D\now nloaded from https://academ ic.oup.com /eurheartj/article/44/12/1020/7017633 by Indian Institute of Technology Patna user on 13 January 2024\n82. Echahidi N, Pibarot P, O\u2019Hara G, Mathieu P. Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery. J Am Coll Cardiol 2008;51:793\u2013801. https://doi. org/10.1016/j.jacc.2007.10.043 83. Lin MH, Kamel H, Singer DE, Wu YL, Lee M, Ovbiagele B. Perioperative/postoperative atrial fibrillation and risk of subsequent stroke and/or mortality. Stroke 2019;50: 1364\u20131371. https://doi.org/10.1161/STROKEAHA.118.023921 84. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstr\u00f6m-Lundqvist C, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European society of cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 2021;42:373\u2013498. https://doi.org/10.1093/eurheartj/ehaa612 85. Kim SH, Jang M-J, Hwang HY. Perioperative beta-blocker for atrial fibrillation after cardiac surgery: a meta-analysis. Thorac Cardiovasc Surg 2021;69:133\u2013140. https://doi.org/ 10.1055/s-0040-1708472 86. Arsenault KA, Yusuf AM, Crystal E, Healey JS, Morillo CA, Nair GM, et al. Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery. Cochrane Database Syst Rev 2013;2013:CD003611. https://doi.org/10.1002/ 14651858.CD003611.pub3 87. Khan MF, Wendel CS, Movahed MR. Prevention of post-coronary artery bypass grafting (CABG) atrial fibrillation: efficacy of prophylactic beta-blockers in the modern era: a meta-analysis of latest randomized controlled trials. Ann Noninvasive Electrocardiol 2013;18:58\u201368. https://doi.org/10.1111/anec.12004 88. Study Group POISE, Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008;371:1839\u20131847. https://doi. org/10.1016/S0140-6736(08)60601-7 89. Blessberger H, Lewis SR, Pritchard MW, Fawcett LJ, Domanovits H, Schlager O, et al. Perioperative beta-blockers for preventing surgery-related mortality and morbidity in adults undergoing non-cardiac surgery. Cochrane Database Syst Rev 2019;9:CD013438. https://doi.org/10.1002/14651858.CD013438 90. Nattel S. The molecular and ionic specificity of antiarrhythmic drug actions. J Cardiovasc Electrophysiol 1999;10:272\u2013282. https://doi.org/10.1111/j.1540-8167.1999.tb00673.x 91. Mitchell LB, Exner DV, Wyse DG, Connolly CJ, Prystai GD, Bayes AJ, et al. Prophylactic oral amiodarone for the prevention of arrhythmias that begin early after revascularization, valve replacement, or repair: PAPABEAR: a randomized controlled trial. JAMA 2005;294:3093\u20133100. https://doi.org/10.1001/jama.294.24.3093 92. Buckley MS, Nolan PE, Slack MK, Tisdale JE, Hilleman DE, Copeland JG. Amiodarone prophylaxis for atrial fibrillation after cardiac surgery: meta-analysis of dose response and timing of initiation. Pharmacotherapy 2007;27:360\u2013368. https://doi.org/10.1592/ phco.27.3.360 93. Goldschlager N, Epstein AE, Naccarelli G, Olshansky B, Singh B. Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology. Arch Intern Med 2000; 160:1741\u20131748. https://doi.org/10.1001/archinte.160.12.1741 94. Ashrafian H, Davey P. Is amiodarone an underrecognized cause of acute respiratory failure in the ICU? Chest 2001;120:275\u2013282. https://doi.org/10.1378/chest.120.1.275 95. Saussine M, Colson P, Alauzen M, Mary H. Postoperative acute respiratory distress syndrome. A complication of amiodarone associated with 100% oxygen ventilation. Chest 1992;102:980\u2013981. https://doi.org/10.1378/chest.102.3.980 96. Burgess DC, Kilborn MJ, Keech AC. Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis. Eur Heart J 2006;272:2846\u20132857. https://doi.org/10.1093/eurheartj/ehl272 97. Mooss AN, Wurdeman RL, Sugimoto JT, Packard KA, Hilleman DE, Lenz TL, et al. Amiodarone versus sotalol for the treatment of atrial fibrillation after open heart surgery: the Reduction in Postoperative Cardiovascular Arrhythmic Events (REDUCE) trial. Am Heart J 2004;148:641\u2013648. https://doi.org/10.1016/j.ahj.2004.04.031 98. Wijeysundera DN, Beattie WS, Rao V, Karski J. Calcium antagonists reduce cardiovascular complications after cardiac surgery: a meta-analysis. J Am Coll Cardiol 2003;41: 1496\u20131505. https://doi.org/10.1016/s0735-1097(03)00191-8 99. Parikka H, Toivonen L, Pellinen T, Verkkala K, Jarvinen A, Nieminen MS. The influence of intravenous magnesium sulphate on the occurrence of atrial fibrillation after coronary artery by-pass operation. Eur Heart J 1993;14:251\u2013258. https://doi.org/10.1093/ eurheartj/14.2.251 100. Baradari A G, Zeydi A E, Ghafari R, Aarabi M, Jafari M. A double-blind randomized clinical trial comparing different doses of magnesium in cardioplegic solution for prevention of atrial fibrillation after coronary artery bypass graft surgery. Cardiovasc Ther 2016;34:276\u2013282. https://doi.org/10.1111/1755-5922.12198 101. Klinger RY, Thunberg CA, White WD. Intraoperative magnesium administration does not reduce postoperative atrial fibrillation after cardiac surgery. Anesth Analg 2015; 121:861\u2013867. https://doi.org/10.1213/ANE.0000000000000873 102. Miller S, Crystal E, Garfinkle M, Lau C, Lashevsky I, Connolly SJ. Effects of magnesium on atrial fibrillation after cardiac surgery: a meta-analysis. Heart 2005;91:618\u2013623. https://doi.org/10.1136/hrt.2004.033811\n103. Cook RC, Yamashita MH, Kearns M, Ramanathan K, Gin K, Humphries KH. Prophylactic magnesium does not prevent atrial fibrillation after cardiac surgery: a meta-analysis. Ann Thorac Surg 2013;95:533\u2013541. https://doi.org/10.1016/j. athoracsur.2012.09.008 104. Tabbalat RA, Alhaddad I, Hammoudeh A, Khader YS, Khalaf HA, Obaidat M, et al. Effect of low-dose ColchiciNe on the InciDence of atrial fibrillation in open heart surgery patients: END-AF low dose trial. J Int Med Res 2020;48:300060520939832. https://doi.org/10.1177/0300060520939832 105. Levy T, Fotopoulos G, Walker S, Rex S, Octave M, Paul V, et al. Randomized controlled study investigating the effect of biatrial pacing in prevention of atrial fibrillation after coronary artery bypass grafting. Circulation 2000;102:1382\u20131387. https://doi.org/10. 1161/01.cir.102.12.1382 106. Gerstenfeld EP, Khoo M, Martin RC. Effectiveness of bi-atrial pacing for reducing atrial fibrillation after coronary artery bypass graft surgery. J Interv Card Electrophysiol 2001;5: 275\u2013283. https://doi.org/10.1023/a:1011412715439 107. Ruan Y, Robinson NB, Naik A. Effect of atrial pacing on post-operative atrial fibrillation following coronary artery bypass grafting: pairwise and network meta-analyses. Int J Cardiol 2020;302:103\u2013107. https://doi.org/10.1016/j.ijcard.2019.12.009 108. Xiong T, Pu L, Ma Y-F, Zhu Y-L, Li H, Cui X, et al. Posterior pericardiotomy to prevent new-onset atrial fibrillation after coronary artery bypass grafting: a systematic review and meta-analysis of 10 randomized controlled trials. J Cardiothorac Surg 2021;16:233. https://doi.org/10.1186/s13019-021-01611-x 109. Liu S, Jing Y, Zhang J, Bian C, Zhang YU, Zhang X. Does anterior fat pad removal reduce the incidence of atrial fibrillation after CABG? A meta-analysis of randomized controlled trials. Pacing Clin Electrophysiol 2015;38:1363\u20131368. https://doi.org/10.1111/ pace.12740 110. Pokushalov E, Kozlov B, Romanov A, Strelnikov A, Bayramova S, Sergeevichev D, et al. Botulinum toxin injection in epicardial fat pads can prevent recurrences of atrial fibrillation after cardiac surgery: results of a randomized pilot study. J Am Coll Cardiol 2014; 64:628\u2013629. https://doi.org/10.1016/j.jacc.2014.04.062 111. Piccini JP, Ahlsson A, Dorian P, Gillinov MA, Kowey PR, Mack MJ, et al. Design and rationale of a phase 2 study of NeurOtoxin (botulinum toxin type A) for the PreVention of post-operative atrial fibrillation\u2014the NOVA study. Am Heart J 2022;245:51\u201359. https://doi.org/10.1016/j.ahj.2021.10.114 112. Al-Atassi T, Toeg H, Malas T, Lam BK. Mapping and ablation of autonomic ganglia in prevention of postoperative atrial fibrillation in coronary surgery: MAAPPAFS atrial fibrillation randomized controlled pilot study. Can J Cardiol 2014;30:1202\u20131207. https://doi.org/10.1016/j.cjca.2014.04.018 113. Kiaii B, Fox S, Chase L, Fernandes M, Stitt LW, Guo R, et al. Postoperative atrial fibrillation is not pulmonary vein dependent: results from a randomized trial. Heart Rhythm 2015;12:699\u2013705. https://doi.org/10.1016/j.hrthm.2015.01.014 114. Al-Khatib SM, Hafley G, Harrington RA. Patterns of management of atrial fibrillation complicating coronary artery bypass grafting: results from the PRoject of ex-vivo vein graft ENgineering via transfection IV (PREVENT-IV) trial. Am Heart J 2009;158: 792\u2013798. https://doi.org/10.1016/j.ahj.2009.09.003 115. Lee JK, Klein GJ, Krahn AD, Yee R, Zarnke K, Simpson C, et al. Rate-control versus conversion strategy in postoperative atrial fibrillation: trial design and pilot study results. Card Electrophysiol Rev 2003;7:178\u2013184. https://doi.org/10.1023/A:1027428003609 116. Gillinov AM, Bagiella E, Moskowitz AJ, Raiten JM, Groh MA, Bowdish ME, et al. Rate control versus rhythm control for atrial fibrillation after cardiac surgery. N Engl J Med 2016;374:1911\u20131921. https://doi.org/10.1056/NEJMoa1602002 117. Carnicelli AP, Hong H, Connolly SJ. Direct oral anticoagulants versus warfarin in patients with atrial fibrillation: patient-level network meta-analyses of randomized clinical trials with interaction testing by age and sex. Circulation 2022;145:242\u2013255. https://doi. org/10.1161/CIRCULATIONAHA.121.056355 118. Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 1999;131:492\u2013501. 119. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC, et al. 2014 AHA/ ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2014;64:e1\u201376. https://doi.org/10.1016/j.jacc.2014.03.022 120. Butt JH, Xian Y, Peterson ED, Olsen PS, R\u00f8rth R, Gundlund A, et al. Long-term thromboembolic risk in patients with postoperative atrial fibrillation after coronary artery bypass graft surgery and patients with nonvalvular atrial fibrillation. JAMA Cardiol 2018;3:417\u2013424. https://doi.org/10.1001/jamacardio.2018.0405 121. Riad FS, Grau-Sepulveda M, Jawitz OK. Anticoagulation in new-onset postoperative atrial fibrillation: an analysis from the society of thoracic surgeons adult cardiac surgery database. Heart Rhythm O2 2022;3:325\u2013332. https://doi.org/10.1016/j.hroo.2022.06. 003 122. January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC, et al. 2019 AHA/ ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/ American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2019;74:104\u2013132. https://doi.org/10.1016/j. jacc.2019.01.011\nPOAF mechanisms and treatment 1039 D\now nloaded from https://academ ic.oup.com /eurheartj/article/44/12/1020/7017633 by Indian Institute of Technology Patna user on 13 January 2024"
        }
    ],
    "title": "Postoperative atrial fibrillation: from mechanisms to treatment",
    "year": 2023
}